1,598 results on '"Parathyroid Glands metabolism"'
Search Results
2. Thyroid and parathyroid function disorders induced by short-term exposure of microplastics and nanoplastics: Exploration of toxic mechanisms and early warning biomarkers.
- Author
-
Zhang J, Liu L, Dai X, Li B, Zhang S, and Yu Y
- Subjects
- Animals, Biomarkers metabolism, Parathyroid Glands drug effects, Parathyroid Glands metabolism, Parathyroid Hormone, Male, Mice, Thyroid Diseases chemically induced, Parathyroid Diseases, Thyroglobulin metabolism, Thyroglobulin genetics, Microplastics toxicity, Thyroid Gland drug effects, Thyroid Gland metabolism, Nanoparticles toxicity, PAX8 Transcription Factor genetics
- Abstract
Human exposure to micro- and nano-plastics (MNPs) primarily occurs through respiration and diet in the environment. However, the early effects and warning signs of MNPs exposure on vertebrates are unclear. Here we used intratracheal instillation and intragastric infusion to establish mouse models for MNPs exposure to systematically investigate the toxic mechanisms of MNPs on endocrine organs. Results showed that MNPs induced endocrine disruptions in short-term exposure by both dietary and respiratory pathways. Microplastics (MPs) exposed through dietary route were more toxic to thyroid gland, whereas nanoplastics (NPs) exhibited the highest level of toxicity to parathyroid gland through respiration. The transcriptome and validation of related functional genes revealed that MNPs affected the synthesis of thyroglobulin by interfering with the expressions of PAX8 and CREB. MNPs also impacted the levels of thyroid stimulating hormone, further mediating the secretion of thyroid hormones. Moreover, MNPs modulate the expression of Mafb, thereby exerting regulatory effects on parathyroid hormone (PTH) synthesis and growth development in parathyroid cells. Meanwhile, MNPs interfered with the expression of IP3R in the calcium signaling pathway, indirectly affecting the secretion of PTH. This study reveals the effects and mechanisms of MNPs on thyroid and parathyroid and highlights the significance of early warning of MNPs exposure., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids.
- Author
-
Wang G, Du Y, Cui X, Xu T, Li H, Dong M, Li W, Li Y, Cai W, Xu J, Li S, Yang X, Wu Y, Chen H, and Li X
- Subjects
- Humans, Cells, Cultured, Cell Culture Techniques methods, Nuclear Proteins, Cell Differentiation, Organoids cytology, Organoids metabolism, Human Embryonic Stem Cells cytology, Human Embryonic Stem Cells metabolism, Parathyroid Glands cytology, Parathyroid Glands metabolism, Parathyroid Hormone metabolism, Transcription Factors metabolism, Transcription Factors genetics
- Abstract
Differentiation of human embryonic stem cells (hESCs) into human embryonic stem cells-derived parathyroid-like cells (hESC-PT) has clinical significance in providing new therapies for congenital and acquired parathyroid insufficiency conditions. However, a highly reproducible, well-documented method for parathyroid differentiation remains unavailable. By imitating the natural process of parathyroid embryonic development, we proposed a new hypothesis about the in vitro differentiation of parathyroid-like cells. Transcriptome, differentiation marker protein detection and parathyroid hormone (PTH) secretion assays were performed after the completion of differentiation. To optimize the differentiation protocol and further improve the differentiation rate, we designed glial cells missing transcription factor 2 (GCM2) overexpression lentivirus transfection assays and constructed hESCs-derived parathyroid organoids. The new protocol enabled hESCs to differentiate into hESC-PT. HESC-PT cells expressed PTH, GCM2 and CaSR proteins, low extracellular calcium culture could stimulate hESC-PT cells to secrete PTH. hESC-PT cells overexpressing GCM2 protein secreted PTH earlier than their counterpart hESC-PT cells. Compared with the two-dimensional cell culture environment, hESCs-derived parathyroid organoids secreted more PTH. Both GCM2 lentiviral transfection and three-dimensional cultures could make hESC-PT cells functionally close to human parathyroid cells. Our study demonstrated that hESCs could differentiate into hESC-PT in vitro, which paves the road for applying the technology to treat hypoparathyroidism and introduces new approaches in the field of regenerative medicine., (© 2024 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
4. Exploring near-infrared autofluorescence properties in parathyroid tissue: an analysis of fresh and paraffin-embedded thyroidectomy specimens.
- Author
-
Wang B, Zhou CP, Ao W, Cai SJ, Ge ZW, Wang J, Huang WY, Yu JF, Wu SB, Yan SY, Zhang LY, Wang SS, Wang ZH, Hua S, Abdelhamid Ahmed AH, Randolph GW, and Zhao WX
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Paraffin Embedding methods, Aged, Thyroid Cancer, Papillary surgery, Thyroid Cancer, Papillary pathology, Thyroid Cancer, Papillary metabolism, Receptors, Calcium-Sensing metabolism, Receptors, Calcium-Sensing analysis, Parathyroid Glands surgery, Parathyroid Glands metabolism, Thyroidectomy, Optical Imaging methods, Spectroscopy, Near-Infrared methods
- Abstract
Significance: Near-infrared autofluorescence (NIRAF) utilizes the natural autofluorescence of parathyroid glands (PGs) to improve their identification during thyroid surgeries, reducing the risk of inadvertent removal and subsequent complications such as hypoparathyroidism. This study evaluates NIRAF's effectiveness in real-world surgical settings, highlighting its potential to enhance surgical outcomes and patient safety., Aim: We evaluate the effectiveness of NIRAF in detecting PGs during thyroidectomy and central neck dissection and investigate autofluorescence characteristics in both fresh and paraffin-embedded tissues., Approach: We included 101 patients diagnosed with papillary thyroid cancer who underwent surgeries in 2022 and 2023. We assessed NIRAF's ability to locate PGs, confirmed via parathyroid hormone assays, and involved both junior and senior surgeons. We measured the accuracy, speed, and agreement levels of each method and analyzed autofluorescence persistence and variation over 10 years, alongside the expression of calcium-sensing receptor (CaSR) and vitamin D., Results: NIRAF demonstrated a sensitivity of 89.5% and a negative predictive value of 89.1%. However, its specificity and positive predictive value (PPV) were 61.2% and 62.3%, respectively, which are considered lower. The kappa statistic indicated moderate to substantial agreement (kappa = 0.478; P < 0.001 ). Senior surgeons achieved high specificity (86.2%) and PPV (85.3%), with substantial agreement (kappa = 0.847; P < 0.001 ). In contrast, junior surgeons displayed the lowest kappa statistic among the groups, indicating minimal agreement (kappa = 0.381; P < 0.001 ). Common errors in NIRAF included interference from brown fat and eschar. In addition, paraffin-embedded samples retained stable autofluorescence over 10 years, showing no significant correlation with CaSR and vitamin D levels., Conclusions: NIRAF is useful for PG identification in thyroid and neck surgeries, enhancing efficiency and reducing inadvertent PG removals. The stability of autofluorescence in paraffin samples suggests its long-term viability, with false positives providing insights for further improvements in NIRAF technology., (© 2024 The Authors.)
- Published
- 2025
- Full Text
- View/download PDF
5. Single-cell analysis reveals transcriptional dynamics in healthy primary parathyroid tissue.
- Author
-
Venkat A, Carlino MJ, Lawton BR, Prasad ML, Amodio M, Gibson CE, Zeiss CJ, Youlten SE, Krishnaswamy S, and Krause DS
- Subjects
- Humans, Animals, Transcriptome, Chemokines metabolism, Chemokines genetics, Parathyroid Hormone metabolism, Parathyroid Hormone genetics, Cell Communication, Epithelial Cells metabolism, Gene Expression Profiling methods, Transcription, Genetic, Single-Cell Analysis methods, Parathyroid Glands metabolism, Macaca mulatta
- Abstract
Studies on human parathyroids are generally limited to hyperfunctioning glands owing to the difficulty in obtaining normal human tissue. We therefore obtained non-human primate (NHP) parathyroids to provide a suitable alternative for sequencing that would bear a close semblance to human organs. Single-cell RNA expression analysis of parathyroids from four healthy adult M. mulatta reveals a continuous trajectory of epithelial cell states. Pseudotime analysis based on transcriptomic signatures suggests a progression from GCM2
hi progenitors to mature parathyroid hormone ( PTH )-expressing epithelial cells with increasing core mitochondrial transcript abundance along pseudotime. We sequenced, as a comparator, four histologically characterized hyperfunctioning human parathyroids with varying oxyphil and chief cell abundance and leveraged advanced computational techniques to highlight similarities and differences from non-human primate parathyroid expression dynamics. Predicted cell-cell communication analysis reveals abundant endothelial cell interactions in the parathyroid cell microenvironment in both human and NHP parathyroid glands. We show abundant RARRES2 transcripts in both human adenoma and normal primate parathyroid cells and use coimmunostaining to reveal high levels of RARRES2 protein (also known as chemerin) in PTH-expressing cells, which could indicate that RARRES2 plays an unrecognized role in parathyroid endocrine function. The data obtained are the first single-cell RNA transcriptome to characterize nondiseased parathyroid cell signatures and to show a transcriptomic progression of cell states within normal parathyroid glands, which can be used to better understand parathyroid cell biology., (© 2024 Venkat et al.; Published by Cold Spring Harbor Laboratory Press.)- Published
- 2024
- Full Text
- View/download PDF
6. Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays.
- Author
-
Höppner J and Jüppner H
- Subjects
- Humans, Receptors, Calcium-Sensing genetics, Receptors, Calcium-Sensing metabolism, Parathyroid Glands metabolism, Rare Diseases diagnosis, Rare Diseases genetics, Animals, Renal Insufficiency, Chronic diagnosis, Renal Insufficiency, Chronic genetics, Renal Insufficiency, Chronic metabolism, Calcium metabolism, Genetic Predisposition to Disease, Predictive Value of Tests, Receptor, Parathyroid Hormone, Type 1 metabolism, Receptor, Parathyroid Hormone, Type 1 genetics, Parathyroid Hormone metabolism, Parathyroid Hormone blood, Parathyroid Hormone genetics, Mutation
- Abstract
Purpose of Review: Parathyroid hormone (PTH) is the major peptide hormone regulator of blood calcium homeostasis. Abnormal PTH levels can be observed in patients with various congenital and acquired disorders, including chronic kidney disease (CKD). This review will focus on rare human diseases caused by PTH mutations that have provided insights into the regulation of PTH synthesis and secretion as well as the diagnostic utility of different PTH assays., Recent Findings: Over the past years, numerous diseases affecting calcium and phosphate homeostasis have been defined at the molecular level that are responsible for reduced or increased serum PTH levels. The underlying genetic mutations impair parathyroid gland development, involve the PTH gene itself, or alter function of the calcium-sensing receptor (CaSR) or its downstream signaling partners that contribute to regulation of PTH synthesis or secretion. Mutations in the pre sequence of the mature PTH peptide can, for instance, impair hormone synthesis or intracellular processing, while amino acid substitutions affecting the secreted PTH(1-84) impair PTH receptor (PTH1R) activation, or cause defective cleavage of the pro-sequence and thus secretion of a pro- PTH with much reduced biological activity. Mutations affecting the secreted hormone can alter detection by different PTH assays, thus requiring detailed knowledge of the utilized diagnostic test., Summary: Rare diseases affecting PTH synthesis and secretion have offered helpful insights into parathyroid biology and the diagnostic utility of commonly used PTH assays, which may have implications for the interpretation of PTH measurements in more common disorders such as CKD., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Parathyroid-on-a-chip simulating parathyroid hormone secretion in response to calcium concentration.
- Author
-
Lee S, Jung HI, Lee J, Kim Y, Chung J, Kim HS, Lim J, Nam KC, Lim YS, Choi HS, and Kwak BS
- Subjects
- Humans, Organoids metabolism, Organoids cytology, Cells, Cultured, Parathyroid Hormone metabolism, Calcium metabolism, Lab-On-A-Chip Devices, Parathyroid Glands metabolism, Parathyroid Glands cytology, Mesenchymal Stem Cells metabolism, Mesenchymal Stem Cells cytology
- Abstract
The parathyroid gland is an endocrine organ that plays a crucial role in regulating calcium levels in blood serum through the secretion of parathyroid hormone (PTH). Hypoparathyroidism is a chronic disease that can occur due to parathyroid defects, but due to the difficulty of creating animal models of this disease or obtaining human normal parathyroid cells, the evaluation of parathyroid functionality for drug development is limited. Although parathyroid-like cells that secrete PTH have recently been reported, their functionality may be overestimated using traditional culture methods that lack in vivo similarities, particularly vascularization. To overcome these limitations, we obtained parathyroid organoids from tonsil-derived mesenchymal stem cells (TMSCs) and fabricated a parathyroid-on-a-chip, capable of simulating PTH secretion based on calcium concentration. This chip exhibited differences in PTH secretion according to calcium concentration and secreted PTH within the range of normal serum levels. In addition, branches of organoids, which are difficult to observe in animal models, were observed in this chip. This could serve as a guideline for successful engraftment in implantation therapies in the future.
- Published
- 2024
- Full Text
- View/download PDF
8. Gallic acid pretreatment mitigates parathyroid ischemia-reperfusion injury through signaling pathway modulation.
- Author
-
Liu N, Liang H, Hong Y, Lu X, Jin X, Li Y, Tang S, Li Y, and Cao W
- Subjects
- Animals, Cell Proliferation drug effects, Humans, Mice, Signal Transduction drug effects, Reperfusion Injury drug therapy, Reperfusion Injury metabolism, Reperfusion Injury prevention & control, Reperfusion Injury pathology, Gallic Acid pharmacology, Gallic Acid analogs & derivatives, Apoptosis drug effects, Parathyroid Glands metabolism, Parathyroid Glands drug effects, Parathyroid Glands pathology
- Abstract
Thyroid surgery often results in ischemia-reperfusion injury (IRI) to the parathyroid glands, yet the mechanisms underlying this and how to ameliorate IRI remain incompletely explored. Our study identifies a polyphenolic herbal extract-gallic acid (GA)-with antioxidative properties against IRI. Through flow cytometry and CCK8 assays, we investigate the protective effects of GA pretreatment on a parathyroid IRI model and decode its potential mechanisms via RNA-seq and bioinformatics analysis. Results reveal increased apoptosis, pronounced G1 phase arrest, and significantly reduced cell proliferation in the hypoxia/reoxygenation group compared to the hypoxia group, which GA pretreatment mitigates. RNA-seq and bioinformatics analysis indicate GA's modulation of various signaling pathways, including IL-17, AMPK, MAPK, transient receptor potential channels, cAMP, and Rap1. In summary, GA pretreatment demonstrates potential in protecting parathyroid cells from IRI by influencing various genes and signaling pathways. These findings offer a promising therapeutic strategy for hypoparathyroidism treatment., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
9. TRPC3 Is Downregulated in Primary Hyperparathyroidism.
- Author
-
Kirstein E, Schaudien D, Wagner M, Diebolt CM, Bozzato A, Tschernig T, and Englisch CN
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Adult, Immunohistochemistry, Parathyroid Hormone metabolism, TRPC Cation Channels metabolism, TRPC Cation Channels genetics, Hyperparathyroidism, Primary metabolism, Hyperparathyroidism, Primary genetics, Hyperparathyroidism, Primary pathology, Parathyroid Glands metabolism, Parathyroid Glands pathology, TRPC6 Cation Channel metabolism, TRPC6 Cation Channel genetics, Down-Regulation
- Abstract
Transient receptor potential canonical sub-family channel 3 (TRPC3) is considered to play a critical role in calcium homeostasis. However, there are no established findings in this respect with regard to TRPC6. Although the parathyroid gland is a crucial organ in calcium household regulation, little is known about the protein distribution of TRPC channels-especially TRPC3 and TRPC6-in this organ. Our aim was therefore to investigate the protein expression profile of TRPC3 and TRPC6 in healthy and diseased human parathyroid glands. Surgery samples from patients with healthy parathyroid glands and from patients suffering from primary hyperparathyroidism (pHPT) were investigated by immunohistochemistry using knockout-validated antibodies against TRPC3 and TRPC6. A software-based analysis similar to an H-score was performed. For the first time, to our knowledge, TRPC3 and TRPC6 protein expression is described here in the parathyroid glands. It is found in both chief and oxyphilic cells. Furthermore, the TRPC3 staining score in diseased tissue (pHPT) was statistically significantly lower than that in healthy tissue. In conclusion, TRPC3 and TRPC6 proteins are expressed in the human parathyroid gland. Furthermore, there is strong evidence indicating that TRPC3 plays a role in pHPT and subsequently in parathyroid hormone secretion regulation. These findings ultimately require further research in order to not only confirm our results but also to further investigate the relevance of these channels and, in particular, that of TRPC3 in the aforementioned physiological functions and pathophysiological conditions.
- Published
- 2024
- Full Text
- View/download PDF
10. High lymphocyte signature genes expression in parathyroid endocrine cells and its downregulation linked to tumorigenesis.
- Author
-
Geng C, Liu J, Guo B, Liu K, Gong P, Wang B, Wan Q, Sun L, Zhao J, and Song Y
- Subjects
- Humans, Down-Regulation, Carcinogenesis pathology, Cell Transformation, Neoplastic metabolism, Hyperplasia pathology, Lymphocytes metabolism, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Neoplasms genetics, Parathyroid Neoplasms complications, Parathyroid Neoplasms pathology
- Abstract
Background: To date, because of the difficulty in obtaining normal parathyroid gland samples in human or in animal models, our understanding of this last-discovered organ remains limited., Methods: In the present study, we performed a single-cell transcriptome analysis of six normal parathyroid and eight parathyroid adenoma samples using 10 × Genomics platform., Findings: We have provided a detailed expression atlas of parathyroid endocrine cells. Interestingly, we found an exceptional high expression levels of CD4 and CD226 in parathyroid endocrine cells, which were even higher than those in lymphocytes. This unusual expression of lymphocyte markers in parathyroid endocrine cells was associated with the depletion of CD4 T cells in normal parathyroid glands. Moreover, CD4 and CD226 expression in endocrine cells was significantly decreased in parathyroid adenomas, which was associated with a significant increase in Treg counts. Finally, along the developmental trajectory, we discovered the loss of POMC, ART5, and CES1 expression as the earliest signature of parathyroid hyperplasia., Interpretation: We propose that the loss of CD4 and CD226 expression in parathyroid endocrine cells, coupled with an elevated number of Treg cells, could be linked to the pathogenesis of parathyroid adenoma. Our data also offer valuable information for understanding the noncanonical function of CD4 molecule., Funding: This work was supported by the National Key R&D Program of China (2022YFA0806100), National Natural Science Foundation of China (82130025, 82270922, 31970636, 32211530422), Shandong Provincial Natural Science Foundation of China (ZR2020ZD14), Innovation Team of Jinan (2021GXRC048) and the Outstanding University Driven by Talents Program and Academic Promotion Program of Shandong First Medical University (2019LJ007)., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Epigenetic profiling reveals key genes and cis-regulatory networks specific to human parathyroids.
- Author
-
Jung YL, Zhao W, Li I, Jain D, Epstein CB, Bernstein BE, Parangi S, Sherwood R, Robinson-Cohen C, Hsu YH, Park PJ, and Mannstadt M
- Subjects
- Animals, Humans, Parathyroid Hormone genetics, Parathyroid Hormone metabolism, Chromatin genetics, Epigenesis, Genetic, Calcium metabolism, Parathyroid Glands metabolism
- Abstract
In all terrestrial vertebrates, the parathyroid glands are critical regulators of calcium homeostasis and the sole source of parathyroid hormone (PTH). Hyperparathyroidism and hypoparathyroidism are clinically important disorders affecting multiple organs. However, our knowledge regarding regulatory mechanisms governing the parathyroids has remained limited. Here, we present the comprehensive maps of the chromatin landscape of the human parathyroid glands, identifying active regulatory elements and chromatin interactions. These data allow us to define regulatory circuits and previously unidentified genes that play crucial roles in parathyroid biology. We experimentally validate candidate parathyroid-specific enhancers and demonstrate their integration with GWAS SNPs for parathyroid-related diseases and traits. For instance, we observe reduced activity of a parathyroid-specific enhancer of the Calcium Sensing Receptor gene, which contains a risk allele associated with higher PTH levels compared to the wildtype allele. Our datasets provide a valuable resource for unraveling the mechanisms governing parathyroid gland regulation in health and disease., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
12. Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism.
- Author
-
Mao J, You H, Wang M, Ba Y, Qian J, Cheng P, Lu C, and Chen J
- Subjects
- Adult, Animals, Mice, Humans, Oxyphil Cells, Mice, Nude, Cell Transdifferentiation, Sequence Analysis, RNA, Parathyroid Glands metabolism, Hyperparathyroidism, Secondary genetics, Hyperparathyroidism, Secondary therapy
- Abstract
The parathyroid gland is one of the main organs that regulate calcium and phosphorus metabolism. It is mainly composed of chief cells and oxyphil cells. Oxyphil cell counts are low in the parathyroid glands of healthy adults but are dramatically increased in patients with uremia and secondary hyperparathyroidism (SHPT). Increased oxyphil cell counts are related to drug treatment resistance, but the origin of oxyphil cells and the mechanism of proliferation remain unknown. Herein, three types of parathyroid nodules (chief cell nodules, oxyphil cell nodules and mixed nodules, respectively) excised from parathyroid glands of uremic SHPT patients were used for single-cell RNA sequencing (scRNA-seq), other molecular biology studies, and transplantation into nude mice. Through scRNA-seq of parathyroid mixed nodules from three patients with uremic SHPT, we established the first transcriptomic map of the human parathyroid and found a chief-to-oxyphil cell transdifferentiation characterized by gradual mitochondrial enrichment associated with the uremic milieu. Notably, the mitochondrial enrichment and cellular proliferation of chief cell and oxyphil cell nodules decreased significantly after leaving the uremic milieu via transplantation into nude mice. Remarkably, the phenotype of oxyphil cell nodules improved significantly in the nude mice as characterized by decreased mitochondrial content and the proportion of oxyphil cells to chief cells. Thus, our study provides a comprehensive single-cell transcriptome atlas of the human parathyroid and elucidates the origin of parathyroid oxyphil cells and their underlying transdifferentiating mechanism. These findings enhance our understanding of parathyroid disease and may open new treatment perspectives for patients with chronic kidney disease., (Copyright © 2023 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
13. Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism.
- Author
-
Qian X, Li L, Chen L, Shen C, and Tang J
- Subjects
- Animals, Rabbits, Signal Transduction drug effects, Humans, Calcium metabolism, Proto-Oncogene Proteins c-akt metabolism, Phosphatidylinositol 3-Kinases metabolism, Male, Parathyroid Hormone metabolism, Parathyroid Hormone blood, Hypoparathyroidism drug therapy, Hypoparathyroidism etiology, Hypoparathyroidism metabolism, Abietanes pharmacology, Abietanes therapeutic use, Thyroidectomy adverse effects, Parathyroid Glands metabolism, Parathyroid Glands drug effects, Parathyroid Glands surgery, Disease Models, Animal
- Abstract
Background: Thyroidectomy causes impaired blood supply to the parathyroid glands, which leads to hypoparathyroidism. Tanshinone IIA (Tan IIA) is helpful in blood activation and cardiovascular protection. Therefore, the efficacy of Tan IIA in improving hypoparathyroidism was explored in this study., Methods: New Zealand white rabbits were utilized to establish a unilateral parathyroid gland ischemia injury model. The model was created by selectively ligating the main blood supply vessel of one parathyroid gland, and the rabbits were then divided into three groups receiving 1, 5, and 10 mg/kg of Tan IIA. Serum calcium and parathyroid hormone (PTH) levels were measured using specialized assay kits. Immunohistochemistry was used to assess the microvessel density (MVD) in parathyroid glands. Western blotting (WB) was used to analyze protein expression related to the PI3K/AKT signaling pathway and the pathway-associated HIF-1α and VEGF. Moreover, MMP-2 and MMP-9 involved in angiogenesis were detected by WB., Results: Tan IIA treatment effectively restored serum calcium and PTH levels in a dose-dependent manner. Notably, MVD in the parathyroid glands increased significantly, especially at higher doses. The Tan IIA treatment also elevated the p-PI3K/PI3K and p-AKT/AKT ratios, indicating that the PI3K/AKT pathway was reactivated. Moreover, Tan IIA significantly restored the decreased expression levels of VEGF and HIF-1α caused by parathyroid surgery. Additionally, Tan IIA increased MMP-2 and MMP-9 levels., Conclusion: Tan IIA activates the PI3K/AKT pathway, promotes angiogenesis by modulating VEGF, HIF-1α, MMP-2, and MMP-9, thereby further enhancing MVD within the parathyroid glands. This study demonstrates that Tan IIA improved post-thyroidectomy hypoparathyroidism.
- Published
- 2024
- Full Text
- View/download PDF
14. [The role of immunohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of parathyroid glands].
- Author
-
Kim EI, Lavreniuk AA, Urusova LS, Eremkina AK, Elfimova AR, and Mokrysheva NG
- Subjects
- Humans, Diagnosis, Differential, Female, Male, Middle Aged, Adult, Aged, Ki-67 Antigen metabolism, Parathyroid Hormone metabolism, Parathyroid Glands pathology, Parathyroid Glands metabolism, Antigens, CD34 metabolism, Biomarkers, Tumor metabolism, Tumor Suppressor Proteins metabolism, Platelet Endothelial Cell Adhesion Molecule-1, Parathyroid Neoplasms diagnosis, Parathyroid Neoplasms pathology, Parathyroid Neoplasms metabolism, Immunohistochemistry
- Abstract
Differential diagnosis of atypical parathyroid tumors (APT) and parathyroid carcinomas (PC) is important in determining further management and prognosis. Morphologic diagnosis is sometimes difficult, in which case it is supplemented by immunohistochemical (IHC) examination., Objective: Studying the role of IHC analysis in the differential diagnosis of APT and PC., Material and Methods: The study included 44 patients with morphologic diagnosis of the APT established after surgical treatment for primary hyperparathyroidism on the basis of Endocrinology Research Centre during 2018-2023. All cases underwent IHC examination with evaluation of CD31/CD34 and parathormone (PTH) expression for identification of vascular invasion, Ki-67, parafibromin., Results: According to the results of IHC analysis in 8/44 patients (18.2%) the diagnosis of APT was revised in favor of the PC: in 7 of them vascular invasion was detected; in 1 patient the additional series of slices in the surrounding fatty tissue revealed foci of tumor growth, confirmed by positive reaction with antibodies to PTH. According to IHC results, the material was divided into 2 groups: APT and PC. There were no differences in clinical and morphological characteristics, Ki-67% level and parafibromin expression between the groups., Conclusion: Assessment of clinical and laboratory-instrumental data at the preoperative stage does not allow differentiating APT from PC. In case of APT diagnosis and detection of suspicious morphological features, it is necessary to perform IHC examination to exclude PC.
- Published
- 2024
- Full Text
- View/download PDF
15. Expression of the Calcium-Sensing Receptor on Normal and Abnormal Parathyroid and Thyroid Tissue.
- Author
-
Worth AL, Ayrapetyan M, Maygarden SJ, Li Z, Wu Z, Agala CB, and Kim LT
- Subjects
- Humans, Parathyroid Glands diagnostic imaging, Parathyroid Glands metabolism, Receptors, Calcium-Sensing analysis, Receptors, Calcium-Sensing metabolism, Carcinoma, Neuroendocrine pathology, Thyroid Neoplasms pathology
- Abstract
Introduction: Current imaging techniques have several limitations in detecting parathyroid glands. We have investigated the calcium-sensing receptor (CaSR) as a potential target for specifically labeling parathyroid glands for radiologic detection. For accurate imaging it is vital that a large differential expression exists between the target tissue and adjacent structures. We sought to investigate the relative abundance of the CaSR in normal and abnormal parathyroid tissue, as well as normal and abnormal thyroid., Methods: Existing clinical specimens were selected that represented a wide variety of pathologically and clinically confirmed malignant and benign thyroid and parathyroid specimens. Sections were stained for the CaSR using immunohistochemistry and scored for intensity and abundance of expression. (H score = intensity scored from 0 to 3 multiplied by the % of cells at each intensity. Range 0-300)., Results: All parathyroid specimens expressed the CaSR to a high degree. Normal parathyroid had the highest H score (271, s.d. 25.4). Abnormal parathyroid specimens were slightly lower but still much higher than normal thyroid (H score 38.3, s.d. 23.3). Medullary thyroid cancer also expressed the CaSR significantly higher than normal thyroid (H score 182, s.d. 69.1, P < 0.001) but below parathyroid levels. Hürthle cell carcinoma expressed the CaSR to a lesser degree but higher than normal thyroid (H score 101, s.d. 46.4, P = 0.0037)., Conclusions: The CaSR is differentially expressed on parathyroid tissue making it a feasible target for parathyroid imaging. False positives might be anticipated with medullary and Hürthle cell cancers., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
16. The Induction of Parathyroid Cell Differentiation from Human Induced Pluripotent Stem Cells Promoted Via TGF-α/EGFR Signaling.
- Author
-
Nakatsuka R, Kato T, Zhang R, Uemura Y, Sasaki Y, Matsuoka Y, Shirouzu Y, Fujioka T, Yamashita H, Hattori F, Nozaki T, Ogata H, and Hitomi H
- Subjects
- Humans, Hyperplasia metabolism, Hyperplasia pathology, Transforming Growth Factor alpha pharmacology, Transforming Growth Factor alpha metabolism, Epithelial Cell Adhesion Molecule metabolism, Epithelial Cell Adhesion Molecule pharmacology, ErbB Receptors genetics, ErbB Receptors metabolism, Cell Differentiation, Receptors, Calcium-Sensing genetics, Receptors, Calcium-Sensing metabolism, Parathyroid Glands metabolism, Parathyroid Glands pathology, Induced Pluripotent Stem Cells metabolism
- Abstract
The parathyroid gland plays an essential role in mineral and bone metabolism. Cultivation of physiological human parathyroid cells has yet to be established and the method by which parathyroid cells differentiate from pluripotent stem cells remains uncertain. Therefore, it has been hard to clarify the mechanisms underlying the onset of parathyroid disorders, such as hyperparathyroidism. In this study, we developed a new method of parathyroid cell differentiation from human induced pluripotent stem (iPS) cells. Parathyroid cell differentiation occurred in accordance with embryologic development. Differentiated cells, which expressed the parathyroid hormone, adopted unique cell aggregation similar to the parathyroid gland. In addition, these differentiated cells were identified as calcium-sensing receptor (CaSR)/epithelial cell adhesion molecule (EpCAM) double-positive cells. Interestingly, stimulation with transforming growth factor-α (TGF-α), which is considered a causative molecule of parathyroid hyperplasia, increased the CaSR/EpCAM double-positive cells, but this effect was suppressed by erlotinib, which is an epidermal growth factor receptor (EGFR) inhibitor. These results suggest that TGF-α/EGFR signaling promotes parathyroid cell differentiation from iPS cells in a similar manner to parathyroid hyperplasia.
- Published
- 2023
- Full Text
- View/download PDF
17. Innate differences in the molecular signature of normal inferior & superior human parathyroid glands: potential implications for parathyroid adenoma.
- Author
-
Agarwal S, Kar P, Boruah M, Saha S, Millo T, Kumar C, Vuthaluru S, and Goswami R
- Subjects
- Humans, Parathyroid Glands chemistry, Parathyroid Glands metabolism, Parathyroid Glands pathology, Blotting, Western, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Parathyroid Neoplasms genetics, Parathyroid Neoplasms metabolism, Parathyroid Neoplasms pathology, Hyperparathyroidism, Primary metabolism, Hyperparathyroidism, Primary pathology
- Abstract
Primary hyperparathyroidism is a common endocrine disorder. Interestingly, the majority (75%) of parathyroid tumors are localized to the inferior parathyroid glands. To date, the reason for this natural bias has not been investigated. We assessed the global gene expression profile of superior and inferior glands obtained from forensic autopsies. The genes with significant differential expression between superior and inferior parathyroids were further assessed by RT-PCR in 19 pairs. As an iterative approach, additional genes with an established role in parathyroid disorders, i.e., CASR, MAFB, PAX9, TBCE, TBX1, VDR, MEN1, CCND1, and CDC73 were also evaluated by RT-PCR in all 19 pairs of superior and inferior parathyroid glands. Seven homeobox genes, namely HOXA4, HOXA5, HOXBAS3, HOXB4, HOXB6, HOXB9, IRX1, and one encoding for ALDH1A2 showed a lower expression in the inferior parathyroid glands than in the superior. Conversely, SLC6A1 showed a higher expression in the inferior glands. Of the nine genes with significant differential mRNA expression among superior and inferior glands HOXB9, HOXB4 and IRX1 could be detected by western blotting/mass spectrometry. The study is the first to show the differential expression of nine genes HOXA4, HOXA5, HOXBAS3, HOXB4, HOXB6, HOXB9, IRX1, ALDH1A2, and SLC6A1 in inferior versus the superior parathyroid glands. This could have potential implications for the preferential localization of parathyroid tumors to the inferior parathyroid glands as observed in patients with primary hyperparathyroidism., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
18. Potential impacts of SARS-CoV-2 on parathyroid: current advances and trends.
- Author
-
Murugan AK and Alzahrani AS
- Subjects
- Humans, Furin metabolism, COVID-19 Vaccines, Parathyroid Glands metabolism, Angiotensin-Converting Enzyme 2, Post-Acute COVID-19 Syndrome, Peptidyl-Dipeptidase A, SARS-CoV-2, COVID-19
- Abstract
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection affects several important organs including endocrine glands. Experimental studies demonstrated that the virus exploits the ACE2, a transmembrane glycoprotein on the cell surface as a receptor for cellular entry. This entry process is exclusively facilitated by other intracellular protein molecules such as TMPRSS2, furin, NRP1, and NRP2. Recent findings documented the involvement of the SARS-CoV-2 in inducing various parathyroid disorders including hypoparathyroidism and hypocalcemia, which received significant attention. This review extensively describes rapidly evolving knowledge on the potential part of SARS-CoV-2 in emerging various parathyroid disorders due to SARS-CoV-2 infection particularly parathyroid malfunction in COVID-19 cases, and post-COVID-19 conditions. Further, it presents the expression level of various molecules such as ACE2, TMPRSS2, furin, NRP1, and NRP2 in the parathyroid cells that facilitate the SARS-CoV-2 entry into the cell, and discusses the possible mechanism of parathyroid gland infection. Besides, it explores parathyroid malfunction in COVID-19 vaccine-administered cases. It also explains the possible long-COVID-19 effect on parathyroid and post-COVID-19 management of parathyroid. A complete understanding of the mechanisms of SARS-CoV-2-triggered pathogenesis in parathyroid dysfunctions may curtail treatment options and aid in the management of SARS-CoV-2-infected cases., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
19. Effects of evocalcet on parathyroid calcium-sensing receptor and vitamin D receptor expression in uremic rats.
- Author
-
Saito T, Mizobuchi M, Sakai M, Kawata T, Kitayama T, Kato T, Suzuki T, Ogata H, Koiwa F, and Honda H
- Subjects
- Rats, Animals, Receptors, Calcium-Sensing metabolism, Rats, Sprague-Dawley, Parathyroid Glands metabolism, Parathyroid Hormone metabolism, Cinacalcet pharmacology, Cinacalcet metabolism, Receptors, Calcitriol metabolism, Hyperparathyroidism, Secondary drug therapy, Hyperparathyroidism, Secondary complications, Hyperparathyroidism, Secondary metabolism
- Abstract
Little is known about the effect of the recently developed calcimimetic evocalcet (Evo) on parathyroid calcium-sensing receptor (CaSR) and vitamin D receptor (VDR) expression. We examined the effects of Evo and cinacalcet (Cina) on CaSR and VDR expression in 5/6 nephrectomized Sprague-Dawley rats fed a high-phosphorus diet for 4 weeks to develop secondary hyperparathyroidism (SHPT). These uremic rats were divided into 4 groups-baseline control (Nx4W) and groups with additional treatment with either the Vehicle, Evo, or Cina for 2 weeks; normal rats were used as normal controls (NC). Blood parameters and parathyroid tissue were analyzed. CaSR and VDR expression levels were determined using immunohistochemistry. The degree of kidney injury and hyperphosphatemia was similar in the uremic groups (Nx4W, Vehicle, Cina, and Evo). Serum parathyroid hormone levels were significantly higher in the Nx4W and Vehicle groups than in the NC group. This increase was significantly suppressed in the Cina and Evo groups compared with that in the Vehicle group. Serum calcium levels were significantly and equally lower in the Cina and Evo groups relative to those in the Vehicle group. CaSR expression was significantly lower in the Nx4W and Vehicle groups than in the NC group. This downregulation was of an equally lesser magnitude in the Cina and Evo groups. A similar trend was observed for VDR expression. These results indicate that Evo and Cina treatment can increase parathyroid CaSR and VDR expression in uremic rats with SHPT, which could provide better control of mineral and bone disorder markers., (© 2023 Federation of American Societies for Experimental Biology.)
- Published
- 2023
- Full Text
- View/download PDF
20. Metabolism of parathyroid organoids.
- Author
-
Sekhar KR, Codreanu SG, Williams OC, Rathmell JC, Rathmell WK, McLean JA, Sherrod SD, and Baregamian N
- Subjects
- Humans, Biopsy, Fine-Needle methods, Organoids, Parathyroid Glands metabolism, Thyroid Gland
- Abstract
Introduction: We successfully developed a broad spectrum of patient-derived endocrine organoids (PDO) from benign and malignant neoplasms of thyroid, parathyroid, and adrenal glands. In this study, we employed functionally intact parathyroid PDOs from benign parathyroid tissues to study primary hyperparathyroidism (PHPT), a common endocrine metabolic disease. As proof of concept, we examined the utility of parathyroid PDOs for bioenergetic and metabolic screening and assessed whether parathyroid PDO metabolism recapitulated matched PHPT tissues., Methods: Our study methods included a fine-needle aspiration (FNA)-based technique to establish parathyroid PDOs from human PHPT tissues (n=6) in semi-solid culture conditions for organoid formation, growth, and proliferation. Mass spectrometry metabolomic analysis of PHPT tissues and patient-matched PDOs, and live cell bioenergetic profiling of parathyroid PDOs with extracellular flux analyses, were performed. Functional analysis cryopreserved and re-cultured parathyroid PDOs for parathyroid hormone (PTH) secretion was performed using ELISA hormone assays., Results and Discussion: Our findings support both the feasibility of parathyroid PDOs for metabolic and bioenergetic profiling and reinforce metabolic recapitulation of PHPT tissues by patient-matched parathyroid PDOs. Cryopreserved parathyroid PDOs exhibited preserved, rapid, and sustained secretory function after thawing. In conclusion, successful utilization of parathyroid PDOs for metabolic profiling further affirms the feasibility of promising endocrine organoid platforms for future metabolic studies and broader multiplatform and translational applications for therapeutic advancements of parathyroid and other endocrine applications., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Sekhar, Codreanu, Williams, Rathmell, Rathmell, McLean, Sherrod and Baregamian.)
- Published
- 2023
- Full Text
- View/download PDF
21. High sodium promotes the secretion and synthesis of PTH through PiT-1-IKKβ pathway in parathyroid gland in vitro.
- Author
-
Shen A, Wang Y, Ye G, Mao J, Zhang Q, and Chen J
- Subjects
- Rats, Animals, Parathyroid Hormone, I-kappa B Kinase metabolism, NF-kappa B metabolism, Protein Serine-Threonine Kinases metabolism, Calcium metabolism, Parathyroid Glands metabolism, Hyperparathyroidism, Secondary etiology, Hyperparathyroidism, Secondary metabolism
- Abstract
Parathyroid hormone (PTH) is secreted by the parathyroid glands (PTGs) and is an important hormone regulating mineral metabolism. Previous studies reported that high sodium diet will cause the increase in serum PTH, but the specific mechanism is unknown. Consequently, the present study aims to investigate the effects and mechanisms of high sodium on PTH synthesis and secretion from PTGs. We developed a tissue culture model using normal rat PTGs, discovered that sodium elicited and promoted concentration-dependent and time-dependent PTH secretion. Changes in sodium-associated transporters from PTGs incubated with high sodium were thoroughly examined. Increased expression of sodium-phosphate cotransporter Slc20a1 (also known as PiT-1) was observed. Further tests revealed that PiT-1 activated the NF-κB signaling pathway, resulting in increased IKKβ phosphorylation, IKBα degradation, and increased p65 phosphorylation followed by nuclear entry, which led to increased PTH transcription. Meanwhile, IKKβ phosphorylated SNAP23, promoting exocytosis and eventually led to increased PTH secretion. In conclusion, our findings indicate that PiT-1 plays an important role in the increased secretion and synthesis of PTH directly induced by high sodium under physiological conditions, and may provide a potential therapeutic target for secondary hyperparathyroidism (SHPT)., (© 2023 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.)
- Published
- 2023
- Full Text
- View/download PDF
22. Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.
- Author
-
Zuo J, Hasan AA, Hocher CF, Kalk P, Kleuser B, Krämer BK, and Hocher B
- Subjects
- Animals, Mice, Rats, Calcifediol, Parathyroid Glands metabolism, Parathyroid Hormone, Kidney Transplantation
- Abstract
Background: 25-hydroxyvitamin D (25(OH)D) and potentially also 1,25-dihydroxyvitamin D (1,25(OH)2D) inhibits the synthesis of parathyroid hormone (PTH) in the chief cells of the parathyroid gland. Clinical studies showing a negative correlation between (25(OH)D and PTH are in good agreement with these findings in basic science studies. However, PTH was measured in these studies with the currently clinically used 2nd or 3rd generation intact PTH (iPTH) assay systems. iPTH assays cannot distinguish between oxidized forms of PTH and non-oxidized PTH. Oxidized forms of PTH are the by far most abundant form of PTH in the circulation of patients with impaired kidney function. Oxidation of PTH causes a loss of function of PTH. Given that the clinical studies done so far were performed with an PTH assay systems that mainly detect oxidized forms of PTH, the real relationship between bioactive non-oxidized PTH and 25(OH)D as well as 1,25(OH)2D is still unknown., Methods: To address this topic, we compared for the first time the relationship between 25(OH)D as well as 1,25(OH)2D and iPTH, oxPTH as well as fully bioactive n-oxPTH in 531 stable kidney transplant recipients in the central clinical laboratories of the Charité. Samples were assessed either directly (iPTH) or after oxPTH (n-oxPTH) was removed using a column that used anti-human oxPTH monoclonal antibodies, a monoclonal rat/mouse parathyroid hormone antibody (MAB) was immobilized onto a column with 500 liters of plasma samples. Spearman correlation analysis and Multivariate linear regression were used to evaluate the correlations between the variables., Results: There was an inverse correlation between 25(OH)D and all forms of PTH, including oxPTH (iPTH: r=-0.197, p<0.0001; oxPTH: r=-0.203, p<0.0001; n-oxPTH: r=-0.146, p=0.001). No significant correlation was observed between 1,25(OH)2D and all forms of PTH. Multiple linear regression analysis considering age, PTH (iPTH, oxPTH and n-oxPTH), serum calcium, serum phosphor, serum creatinine, fibroblast growth factor 23 (FGF23), osteoprotegerin (OPG), albumin, and sclerostin as confounding factors confirmed these findings. Subgroup analysis showed that our results are not affected by sex and age., Conclusion: In our study, all forms of PTH are inversely correlated with 25-hydroxyvitamin D (25(OH)D). This finding would be in line with an inhibition of the synthesis of all forms of PTH (bioactive n-oxPTH and oxidized forms of PTH with minor or no bioactivity) in the chief cells of the parathyroid glad., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Zuo, Hasan, Hocher, Kalk, Kleuser, Krämer and Hocher.)
- Published
- 2023
- Full Text
- View/download PDF
23. Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects.
- Author
-
Komaba H
- Subjects
- Humans, Bone and Bones metabolism, Fibroblast Growth Factors metabolism, Parathyroid Glands metabolism, Parathyroid Hormone metabolism, Renal Insufficiency
- Abstract
Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) each play a central role in the pathogenesis of chronic kidney disease-mineral and bone disorder (CKD-MBD). Both hormones increase as kidney function declines, presumably as a response to maintain normal phosphate balance, but when patients reach kidney failure, PTH and FGF23 fail to exert their phosphaturic effects, leading to hyperphosphatemia and further elevations in PTH and FGF23. In patients with kidney failure, the major target organ for PTH is the bone, but elevated PTH is also associated with mortality presumably through skeletal and nonskeletal mechanisms. Indeed, accumulated evidence suggests improved survival with PTH-lowering therapies, and a more recent study comparing parathyroidectomy and calcimimetic treatment further suggests a notion of "the lower, the better" for PTH control. Emerging data suggest that the link between SHPT and mortality could in part be explained by the action of PTH to induce adipose tissue browning and wasting. In the absence of a functioning kidney, the classical target organ for FGF23 is the parathyroid gland, but FGF23 loses its hormonal effect to suppress PTH secretion owing to the depressed expression of parathyroid Klotho. In this setting, experimental data suggest that FGF23 exerts adverse nontarget effects, but it remains to be confirmed whether FGF23 directly contributes to multiple organ injury in patients with kidney failure and whether targeting FGF23 can improve patient outcomes. Further efforts should be made to determine whether intensive control of SHPT improves clinical outcomes and whether nephrologists should aim at controlling FGF23 levels just as with PTH levels., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
24. Osteocalcin modulates parathyroid cell function in human parathyroid tumors.
- Author
-
Verdelli C, Tavanti GS, Forno I, Vaira V, Maggiore R, Vicentini L, Dalino Ciaramella P, Perticone F, Lombardi G, and Corbetta S
- Subjects
- Humans, Osteocalcin metabolism, beta Catenin metabolism, HEK293 Cells, Receptors, Calcium-Sensing metabolism, Parathyroid Glands metabolism, Parathyroid Neoplasms pathology
- Abstract
Introduction: The bone matrix protein osteocalcin (OC), secreted by osteoblasts, displays endocrine effects. We tested the hypothesis that OC modulates parathyroid tumor cell function., Methods: Primary cell cultures derived from parathyroid adenomas (PAds) and HEK293 cells transiently transfected with the putative OC receptor GPRC6A or the calcium sensing receptor (CASR) were used as experimental models to investigate γ-carboxylated OC (GlaOC) or uncarboxylated OC (GluOC) modulation of intracellular signaling., Results: In primary cell cultures derived from PAds, incubation with GlaOC or GluOC modulated intracellular signaling, inhibiting pERK/ERK and increasing active β-catenin levels. GlaOC increased the expression of PTH, CCND1 and CASR , and reduced CDKN1B/p27 and TP73 . GluOC stimulated transcription of PTH , and inhibited MEN1 expression. Moreover, GlaOC and GluOC reduced staurosporin-induced caspase 3/7 activity. The putative OC receptor GPRC6A was detected in normal and tumor parathyroids at membrane or cytoplasmic level in cells scattered throughout the parenchyma. In PAds, the membrane expression levels of GPRC6A and its closest homolog CASR positively correlated; GPRC6A protein levels positively correlated with circulating ionized and total calcium, and PTH levels of the patients harboring the analyzed PAds. Using HEK293A transiently transfected with either GPRC6A or CASR, and PAds-derived cells silenced for CASR , we showed that GlaOC and GluOC modulated pERK/ERK and active β-catenin mainly through CASR activation., Conclusion: Parathyroid gland emerges as a novel target of the bone secreted hormone osteocalcin, which may modulate tumor parathyroid CASR sensitivity and parathyroid cell apoptosis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Verdelli, Tavanti, Forno, Vaira, Maggiore, Vicentini, Dalino Ciaramella, Perticone, Lombardi and Corbetta.)
- Published
- 2023
- Full Text
- View/download PDF
25. Ectopic PTH-producing parathyroid cyst inside the thymus: a case report.
- Author
-
Takenouchi H, Anno T, Harada A, Isobe H, Kimura Y, Kawasaki F, Kaku K, Tomoda K, Fujiwara H, and Kaneto H
- Subjects
- Humans, Adult, Female, Middle Aged, Parathyroid Glands metabolism, Parathyroid Hormone, Hormones, Ectopic, Hypercalcemia complications, Parathyroid Neoplasms complications, Parathyroid Neoplasms diagnosis, Parathyroid Neoplasms surgery, Hyperparathyroidism, Primary complications, Cysts
- Abstract
Background: The hallmark of hyperparathyroidism is hypersecretion of parathyroid hormone (PTH) which results in hypercalcemia and hypophosphatemia. While hypercalcemia due to malignancy is often brought about by PTH-related protein in adults, PTH-producing tumors are quite rare in clinical practice. Additionally, from the point of embryology, it is very difficult to examine ectopic PTH-producing tissue such as ectopic parathyroid glands. Furthermore, clear histopathological criteria are not present., Case Presentation: A 57-year-old woman was referred to our hospital for hypercalcemia. Her parathyroid hormone (PTH) level was elevated, but there were no enlarged parathyroid glands. Although 99mTc-MIBI confirmed a localized and slightly hyperfunctioning parathyroid tissue in the anterior mediastinum, it was not typical as hyperfunctioning parathyroid. We finally diagnosed her as ectopic PTH-producing cyst-like tumor with venous sampling of PTH. She underwent anterosuperior mediastinal ectopic PTH-producing cyst-like tumor resection. It is noted that intact-PTH concentration of the fluid in the cyst was very high (19,960,000 pg/mL). Based on histopathological findings, we finally diagnosed her as ectopic PTH-producing parathyroid cyst inside the thymus. After resection of anterosuperior mediastinal thymus including ectopic PTH-producing parathyroid cyst, calcium and intact-PTH levels were decreased, and this patient was discharged without any sequelae., Conclusions: We should know the possibility of superior mediastinal ectopic PTH-producing parathyroid cyst inside the thymus among subjects with ectopic PTH-producing parathyroid glands. Particularly when the cyst is present in the superior mediastinum, it is necessary to do careful diagnosis based on not only positive but also negative findings in 99mTc-MIBI. It is noted that the patient's bloody fluid in the cyst contained 19,960,000 pg/mL of intact-PTH, and its overflow into blood stream resulted in hyperparathyroidism and hypercalcemia. Moreover, in such cases, the diagnosis is usually confirmed after through histological examination of ectopic PTH-producing parathyroid glands. We think that it is very meaningful to let clinicians know this case., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
26. Advances in the treatment of secondary and tertiary hyperparathyroidism.
- Author
-
Zhang LX, Zhang B, Liu XY, Wang ZM, Qi P, Zhang TY, and Zhang Q
- Subjects
- Humans, Parathyroid Glands metabolism, Parathyroid Hormone metabolism, Parathyroidectomy, Quality of Life, Hyperparathyroidism, Secondary drug therapy, Hyperparathyroidism, Secondary surgery, Hyperparathyroidism, Secondary therapy
- Abstract
Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple organs and systems occur throughout the body due to hyperactivity disorder in SHPT and THPT. This not only decreases the patients' quality of life, but also affects mortality. Since current treatments for these diseases remains unclear, we aimed to develop a comprehensive review of advances in the treatment of SHPT and THPT according to the latest relevant researches., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Zhang, Zhang, Liu, Wang, Qi, Zhang and Zhang.)
- Published
- 2022
- Full Text
- View/download PDF
27. Kidney Failure Alters Parathyroid Pin1 Phosphorylation and Parathyroid Hormone mRNA-Binding Proteins, Leading to Secondary Hyperparathyroidism.
- Author
-
Hassan A, Pollak YE, Kilav-Levin R, Silver J, London N, Nechama M, Ben-Dov IZ, and Naveh-Many T
- Subjects
- Rats, Mice, Animals, Parathyroid Glands metabolism, RNA, Messenger metabolism, Phosphorylation, Parathyroid Hormone, Hyperparathyroidism, Secondary etiology, Kidney Failure, Chronic complications, Renal Insufficiency complications
- Abstract
Background: Secondary hyperparathyroidism (SHP) is a common complication of CKD that increases morbidity and mortality. In experimental SHP, increased parathyroid hormone (PTH) expression is due to enhanced PTH mRNA stability, mediated by changes in its interaction with stabilizing AUF1 and destabilizing KSRP. The isomerase Pin1 leads to KSRP dephosphorylation, but in SHP parathyroid Pin1 activity is decreased and hence phosphorylated KSRP fails to bind PTH mRNA, resulting in high PTH mRNA stability and levels. The up- and downstream mechanisms by which CKD stimulates the parathyroid glands remain elusive., Methods: Adenine-rich high-phosphate diets induced CKD in rats and mice. Parathyroid organ cultures and transfected cells were incubated with Pin1 inhibitors for their effect on PTH expression. Mass spectrometry was performed on both parathyroid and PTH mRNA pulled-down proteins., Results: CKD led to changes in rat parathyroid proteome and phosphoproteome profiles, including KSRP phosphorylation at Pin1 target sites. Furthermore, both acute and chronic kidney failure led to parathyroid-specific Pin1 Ser16 and Ser71 phosphorylation, which disrupts Pin1 activity. Pharmacologic Pin1 inhibition, which mimics the decreased Pin1 activity in SHP, increased PTH expression ex vivo in parathyroid glands in culture and in transfected cells through the PTH mRNA-protein interaction element and KSRP phosphorylation., Conclusions: Kidney failure leads to loss of parathyroid Pin1 activity by inducing Pin1 phosphorylation. This predisposes parathyroids to increase PTH production through impaired PTH mRNA decay that is dependent on KSRP phosphorylation at Pin1-target motifs. Pin1 and KSRP phosphorylation and the Pin1-KSRP- PTH mRNA axis thus drive SHP., (Copyright © 2022 by the American Society of Nephrology.)
- Published
- 2022
- Full Text
- View/download PDF
28. Limits to in vivo fate changes of epithelia in thymus and parathyroid by ectopic expression of transcription factors Gcm2 and Foxn1.
- Author
-
Nagakubo D, Hirakawa M, Iwanami N, and Boehm T
- Subjects
- Animals, Cell Differentiation, Epithelium metabolism, Mice, Parathyroid Glands metabolism, Thymus Gland metabolism, Ectopic Gene Expression, Forkhead Transcription Factors genetics, Forkhead Transcription Factors metabolism, Nuclear Proteins metabolism, Transcription Factors metabolism
- Abstract
The development of the parathyroid and the thymus from the third pharyngeal pouch depends on the activities of the Gcm2 and Foxn1 transcription factors, respectively, whose expression domains sharply demarcate two regions in the developing third pharyngeal pouch. Here, we have generated novel mouse models to examine whether ectopic co-expression of Gcm2 in the thymic epithelium and of Foxn1 in the parathyroid perturbs the establishment of organ fates in vivo. Expression of Gcm2 in the thymic rudiment does not activate a parathyroid-specific expression programme, even in the absence of Foxn1 activity. Co-expression of Foxn1 in the parathyroid fails to impose thymopoietic capacity. We conclude that the actions of Foxn1 and Gcm2 transcription factors are cell context-dependent and that they each require permissive transcription factor landscapes in order to successfully interfere with organ-specific cell fate., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
29. Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.
- Author
-
Mao J, You H, Wang M, Ni L, Zhang Q, Zhang M, and Chen J
- Subjects
- Adult, Calcitriol metabolism, Calcitriol pharmacology, Humans, Oxyphil Cells metabolism, Parathyroid Hormone genetics, Parathyroid Hormone metabolism, Proteomics, Transcriptome, Hyperparathyroidism, Secondary genetics, Hyperparathyroidism, Secondary metabolism, Parathyroid Glands metabolism
- Abstract
Chief cells are the predominant cells in parathyroid glands of healthy adults; however, parathyroid oxyphil cells, whose function is unknown, increase dramatically in patients with secondary hyperparathyroidism (SHPT). Calcitriol and calcimimetics are the most powerful treatments for SHPT, while the mechanisms leading to calcitriol or calcimimetic resistance in oxyphil cell-predominant SHPT are unknown. Here we used transcriptomic and proteomic techniques to characterize oxyphil cells by comparing the differences between chief and oxyphil cell nodules of parathyroid glands in uremic patients. Compared to chief cell nodules, the most marked expression increases in oxyphil cell nodules were for mitochondrion-associated proteins. The mitochondria number and mitochondrial DNA content were also significantly increased in oxyphil cell nodules. Moreover, oxyphil cell nodules expressed parathyroid-specific factors, and exhibited lower levels of proliferation-related proteins but higher synthesis and secretion level of parathyroid hormone (PTH). The protein expression of SHPT-regulating factors, including vitamin-D receptor, calcium-sensing receptor and Klotho, were significantly downregulated in oxyphil cell nodules. Therefore, oxyphil cells characterized by enrich mitochondria in uremic patients showed higher synthesis and secretion of PTH but lower expression of SHPT regulators than chief cells, which may contribute to the pathophysiology of SHPT and the treatment resistance to calcitriol and calcimimetics., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
30. [Cultivation and characterization of primary human parathyroid cells from patients with severe secondary hyperparathyroidism].
- Author
-
Li P, Li G, Liu L, Huang S, Li J, and Wu W
- Subjects
- Humans, Parathyroid Hormone, RNA, Messenger genetics, RNA, Messenger metabolism, Receptors, Calcium-Sensing genetics, Receptors, Calcium-Sensing metabolism, Hyperparathyroidism, Secondary metabolism, Parathyroid Glands metabolism
- Abstract
Objective: To establish an cell model of hyperparathyroidism by isolation, in vitro culture, and identification of parathyroid cells from patients with secondary hyperparathyroidism (SHPT)., Methods: The parathyroid gland tissues obtained from 10 patients with SHPT were dissociated by collagenase digestion for primary culture of the parathyroid cells. Morphological changes and growth characteristics of the cells were assessed by microscopic imaging and cell counting. The mRNA and protein expression levels of parathyroid hormone (PTH), calcium-sensing receptor (CaSR), and glial cells missing 2 (GCM2) in the primary and passaged cells were determined by immunofluorescence, qRT-PCR, and Western blotting., Results: Primary cultures of parathyroid cells were successfully obtained. The cells exhibited a high expression of PTH shown by immunofluorescence assay and had a population doubling time of approximately 71.61 h. PTH secretion in the second-passage (P2) cells was significantly lower than that in the primary (P0) and first-passage (P1) cells ( P < 0.001). Despite a significant downregulation of CaSR mRNA ( P =0.017) and protein ( P =0.006) in P1 cells as compared with P0 cells, no significant differences were found in mRNA and protein expressions of PTH or GCM2 between the two cell generations., Conclusion: Primary cultures of parathyroid cells isolated from SHPT patients by collagenase digestion show similar biological properties to the cells in vivo .
- Published
- 2022
- Full Text
- View/download PDF
31. CaSR expression in normal parathyroid and PHPT: new insights into pathogenesis from an autopsy-based study.
- Author
-
Agarwal S, Kardam S, Chatterjee P, Kumar C, Boruah M, Sharma MC, Tabin M, and Ramakrishnan L
- Subjects
- Adult, Autopsy, Female, Gene Expression Profiling methods, Humans, Immunohistochemistry, Immunologic Techniques methods, Intracellular Calcium-Sensing Proteins metabolism, Male, Hyperparathyroidism, Primary metabolism, Hyperparathyroidism, Primary pathology, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Neoplasms metabolism, Parathyroid Neoplasms pathology, Receptors, Calcium-Sensing analysis
- Abstract
Purpose: Calcium sensing receptor (CaSR), on the surface of normal parathyroid cells, is essential for maintaining serum calcium levels. The normal pattern of CaSR immunostaining remains undefined and is presumptively circumferential. Given the physiological variation in serum calcium, we postulated that CaSR expression could not be uniformly circumferential. Also, cytoplasmic expression has not been evaluated either in normal or pathological tissues. We studied normal parathyroid tissues derived from forensic autopsies and those rimming parathyroid adenomas for membranous and cytoplasmic CaSR immunoexpression. Results were compared with primary hyperparathyroidism (PHPT) to look for any pathogenetic implications., Materials and Methods: We evaluated 34 normal parathyroid tissues from 11 autopsies, 30 normal rims, 45 parathyroid adenoma, 10 hyperplasia, and 7 carcinoma cases. Membranous expression was categorized complete/incomplete and weak/moderate/strong; scored using Her2/Neu and Histo-scores; predominant pattern noted. Cytoplasmic expression was categorized negative/weak/moderate/strong; predominant intensity noted., Results: Normal autopsy-derived parathyroid tissues were Her2/Neu 3 + , but incomplete membranous staining predominated in 85%. Their immune-scores were significantly more than the cases (p < < 0.05). The mean histo-score of normal rims was intermediate between the two (p < < 0.05). Cytoplasmic expression was strong in all autopsy-derived tissues, weak/negative in hyperplasia (100%), moderate in 16% adenomas, and 43% carcinomas., Conclusions: Normal autopsy-derived parathyroid tissues showed strong but predominantly incomplete membranous expression. Surface CaSR expression decreased in PHPT and is probably an early event in parathyroid adenoma, seen even in normal rims. Whether there is a defect in CaSR trafficking from the cytoplasm to the cell surface in adenoma and carcinoma needs further evaluation., (© 2021. Italian Society of Endocrinology (SIE).)
- Published
- 2022
- Full Text
- View/download PDF
32. Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR .
- Author
-
Hao Y, Lei Z, Shi N, Yu L, Ji W, and Zhang X
- Subjects
- Adult, Calcium metabolism, Calcium-Regulating Hormones and Agents therapeutic use, Cinacalcet therapeutic use, HEK293 Cells, Humans, Hypercalcemia blood, Male, Mutation, Parathyroid Glands metabolism, Parathyroid Hormone blood, Phenethylamines pharmacology, Propylamines pharmacology, Receptors, Calcium-Sensing metabolism, Treatment Failure, Hypercalcemia surgery, Parathyroid Glands surgery, Radiofrequency Ablation methods, Receptors, Calcium-Sensing genetics
- Abstract
Objective: We identified a novel inactivating mutation in the calcium-sensing receptor (CaSR) gene in a patient with refractory hypocalciuric hypercalcemia and analyzed its function. The effectiveness of radiofrequency ablation of the parathyroid glands to treat hypercalcemia caused by this mutation was explored., Methods: Clinical data of patients before and after radiofrequency ablation were retrospectively analyzed. The CaSR mutation (D99N) found in the patient was studied in cell lines. HEK-293 cells were transfected with plasmids containing wild-type (WT) or mutant CaSR genes (D99N and W718X). Expression levels of the respective CaSR proteins were measured, and their functions were assessed by examining the effect of NPS R-568 (a CaSR agonist) on intracellular Ca
2+ oscillations and that of exogenous parathyroid hormone (PTH) on intracellular cyclic adenosine monophosphate (cAMP) levels., Results: The effectiveness of pharmacological treatment was poor, whereas radiofrequency ablation of the parathyroid glands resulted in controlled blood calcium and PTH levels in the patient. In cell lines, upon NPS R-568 administration, the amplitude of intracellular Ca2+ oscillations in the D99N group was lower than that in the WT group and higher than that in the W718X group. Upon administration of PTH, intracellular cAMP levels in the D99N group were higher than those in the WT group and lower than those in the W718X group., Conclusion: The homozygous mutation D99N reduced CaSR activity and caused more severe hypocalciuric hypercalcemia. For patients with this type of hypercalcemia and poor response to pharmacological treatments, radiofrequency ablation of the parathyroid glands may be a suitable treatment option., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Hao, Lei, Shi, Yu, Ji and Zhang.)- Published
- 2022
- Full Text
- View/download PDF
33. Parathyroid Cell Differentiation from Progenitor Cells and Stem Cells: Development, Molecular Mechanism, Function, and Tissue Engineering.
- Author
-
Şenkal S and Doğan A
- Subjects
- Calcium metabolism, Cell Differentiation, Humans, Parathyroid Hormone metabolism, Stem Cells metabolism, Tissue Engineering, Hypocalcemia etiology, Hypocalcemia metabolism, Parathyroid Glands metabolism
- Abstract
Parathyroid glands are endocrine organs which are located posterior to thyroid glands and control secretion of parathyroid hormone (PTH) in order to regulate blood calcium level. PTH maintains calcium homeostasis by acting on the bone, kidney, and small intestine. PTH deficiency leads to chronic hypocalcemia, organ calcinosis, kidney and heart failure, painful muscle spasms, neuromuscular problems, and memory problems. Since parathyroid cells have inadequate proliferation potential in culture conditions, their utilization as a cellular therapy option is very limited. Although studies conducted so far include parathyroid cell differentiation from various cell types, problems related to successful cellular differentiation and transplantation still remain. Recently, parathyroid tissue engineering has attracted attention as a potential treatment for the parathyroid-related diseases caused by hypoparathyroidism. Although major progression is made in the construction of tissue engineering protocols using parathyroid cells and biomaterials, PTH secretion to mimic its spontaneous harmony in the body is a challenge. This chapter comprehensively defines the derivation of parathyroid cells from various cell sources including pluripotent stem cells, molecular mechanisms, and tissue engineering applications., (© 2021. Springer Nature Switzerland AG.)
- Published
- 2022
- Full Text
- View/download PDF
34. Incidence and predictive factors of postoperative hypocalcaemia according to type of thyroid surgery in older adults.
- Author
-
Barbier MP, Mingote E, Sforza N, Morosán Allo Y, Lotartaro M, Serrano L, Fossati MP, Meroño T, Faingold C, Sedlinsky C, and Brenta G
- Subjects
- Aged, Calcium, Female, Humans, Incidence, Male, Middle Aged, Parathyroid Glands metabolism, Parathyroid Hormone, Postoperative Complications epidemiology, Postoperative Complications etiology, Thyroid Gland metabolism, Thyroidectomy adverse effects, Hypocalcemia epidemiology, Hypocalcemia etiology
- Abstract
Purpose: Transient hypocalcaemia after thyroid surgery and its possible predictors have not been extensively described in the elderly. This study aimed to establish the frequency of postsurgical transient hypocalcaemia according to the extent of thyroid surgery in older adults and to assess mineral metabolism biochemical parameters as its predictors., Methods: All patients ≥60 years undergoing thyroid surgery were prospectively included. Type of surgery (hemithyroidectomy(HT) or total thyroidectomy(TT)); and preoperative 25OH Vitamin D (25OHD) and pre and 6 (only TT), 24 h and 6 months postsurgical serum levels of calcium, magnesium, phosphate and parathormone (PTH) were considered. Postsurgical hypoparathyroidism (hPTpost) was defined at PTH levels ≤11 pg/mL., Results: Out of 46 patients (87% female), age (mean ± SD) 70.1 ± 6.2 years, 24 h postsurgical hypocalcaemia was found in ten patients (22%). In 25 (54%) TT patients, 36% and 16% had postsurgical hypocalcaemia at 6 and 24 h respectively; 28% hPTpost but no definitive hPT was recorded and 44% had 25OHD deficiency. Lower 24 h magnesium levels were found in those TT patients with 24 h hypocalcaemia (1.6 ± 0.1 vs 1.9 ± 0.1 mg/dL (p = 0.005)). Among 21 (46%) HT patients, 28.6% had 24 h postsurgical hypocalcaemia; 9.5% had hPTpost. A positive correlation was observed between preoperative 25OHD and 24 h calcaemia (r:0.51,p = 0.02). 43% of the patients were 25OHD deficient, in whom 55% had 24 h hypocalcaemia vs only 9% in the 25OHD sufficient group (p = 0.049)., Conclusion: Postsurgical hypocalcaemia was common in elderly thyroidectomized patients. After TT, lower magnesium levels were found in those patients with 24 h hypocalcaemia. In the HT group, preoperative 25OHD deficiency predicted lower postsurgical calcium levels., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
35. Gene expression profiles in parathyroid adenoma and normal parathyroid tissue.
- Author
-
Kim SW
- Subjects
- Humans, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Hormone genetics, Parathyroid Hormone metabolism, Peptide Hydrolases genetics, Peptide Hydrolases metabolism, SEC Translocation Channels genetics, SEC Translocation Channels metabolism, Transcriptome, Adenoma genetics, Adenoma metabolism, Adenoma pathology, Parathyroid Neoplasms genetics, Parathyroid Neoplasms metabolism, Parathyroid Neoplasms pathology
- Abstract
A parathyroid adenoma comprises 80-85% as a cause of primary hyperparathyroidism. The clonal origin of most parathyroid adenomas suggests a defect at the level of the gene controlling growth of the parathyroid cell or the expression of parathyroid hormone (PTH). Two genes, MEN1 and CCND1, a tumor suppressor and a proto-oncogene respectively, have been solidly established as primary tumorigenic drivers in parathyroid adenomas. As well, germline and somatic mutation of other genes involved in cell cycle regulation or PTH regulation have been discovered in parathyroid adenomas. Moreover, comparative genomic studies between parathyroid adenomas and normal parathyroid tissues have suggested more complex genetic landscape. Microarray analysis have revealed differential expression profiles of genes involved in cell cycle regulation, growth factors, apoptotic pathway, or PTH synthesis or regulation pathway such as CASR, GCM2 and KL (Klotho). Furthermore, recent next-generation sequencing analysis reconfirmed previous finding or revealed novel finding, suggesting signal peptidase complex subunit (SPCS2), ribosomal proteins (RPL23, RPL26, RPN1, RPS25), the endoplasmic reticulum membrane (SEC11C, SEC11A, SEC61G), Klotho, cyclin D1, β-catenin, VDR, CaSR and GCM2 may be important factors contributing to the parathyroid adenoma., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
36. Phosphate Metabolism and Pathophysiology in Parathyroid Disorders and Endocrine Tumors.
- Author
-
Zavatta G, Altieri P, Vandi G, Vicennati V, Pagotto U, and Vescini F
- Subjects
- Bone and Bones metabolism, Calcium blood, Humans, Hyperparathyroidism, Primary pathology, Hypoparathyroidism pathology, Hypophosphatemia pathology, Phosphates metabolism, Multiple Endocrine Neoplasia pathology, Osteomalacia pathology, Parathyroid Diseases pathology, Parathyroid Glands metabolism, Phosphates blood
- Abstract
The advent of new insights into phosphate metabolism must urge the endocrinologist to rethink the pathophysiology of widespread disorders, such as primary hyperparathyroidism, and also of rarer endocrine metabolic bone diseases, such as hypoparathyroidism and tumor-induced hypophosphatemia. These rare diseases of mineral metabolism have been and will be a precious source of new information about phosphate and other minerals in the coming years. The parathyroid glands, the kidneys, and the intestine are the main organs affecting phosphate levels in the blood and urine. Parathyroid disorders, renal tubule defects, or phosphatonin-producing tumors might be unveiled from alterations of such a simple and inexpensive mineral as serum phosphate. This review will present all these disorders from a 'phosphate perspective'.
- Published
- 2021
- Full Text
- View/download PDF
37. Evaluation of the diagnostic utility of the aminotransferase/lactate dehydrogenase ratio for the suspension of tissue specimens during thyroid surgery for the identification of parathyroid tissue.
- Author
-
Fujishima M, Miyauchi A, Ito Y, Kudo T, Noda T, Sasaki T, Sano T, Ando T, Yamamoto M, Masuoka H, Higashiyama T, Kihara M, Hayashi T, Hirokawa M, Onoda N, and Miya A
- Subjects
- Humans, Hypoparathyroidism etiology, Parathyroid Glands metabolism, Sensitivity and Specificity, Thyroid Cancer, Papillary metabolism, Thyroid Cancer, Papillary surgery, Thyroid Gland metabolism, Thyroid Neoplasms metabolism, Thyroid Neoplasms surgery, Hypoparathyroidism prevention & control, L-Lactate Dehydrogenase metabolism, Parathyroid Glands surgery, Postoperative Complications prevention & control, Thyroid Gland surgery, Thyroidectomy adverse effects, Transaminases metabolism
- Abstract
Identification of the parathyroid glands during surgery is crucial for preventing postoperative hypoparathyroidism. Kikumori et al. reported that the aspartate aminotransferase (AST)/lactate dehydrogenase (LDH) ratio for the saline suspension of a suspicious tissue can differentiate parathyroid tissue from other tissues. The aim of this study was to evaluate the utility of this method and investigate the appropriate time for measurement. We obtained 465 tissue specimens during thyroidectomy of 102 patients with papillary thyroid carcinoma (PTC), and 422 specimens (129 parathyroid, 92 PTC, and 201 other tissues) with measurable AST and LDH were analyzed. Small pieces of the tissues were immersed in saline and sent for measurement of AST and LDH. The assay was performed immediately after thyroidectomy for 245 specimens (the same-day group) and during the next morning for the remaining 177 specimens (the next-day group). The accuracy of diagnosing parathyroid tissue was significantly better in the same-day group than in the next-day group. A cut-off value of 0.18 gave the best diagnostic precision, with an area under the receiver operating characteristic curve of 0.95 and 88.7% sensitivity and specificity in the same-day group. When the cut-off value was set to 0.20, the specificity for excluding carcinomatous tissues was 100%. When measured on the day of the surgery, the AST/LDH ratio for the saline suspension of the surgical specimens is useful for discriminating parathyroid tissues from other tissues. This method can be utilized at most hospitals where intraoperative frozen sections or rapid parathyroid hormone assays are not available.
- Published
- 2021
- Full Text
- View/download PDF
38. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
- Author
-
Singh P, Bhadada SK, Dahiya D, Saikia UN, Arya AK, Sachdeva N, Kaur J, Behera A, Brandi ML, and Rao SD
- Subjects
- Adult, Case-Control Studies, Cell Line, Tumor, Epigenesis, Genetic genetics, Female, Gene Silencing, Humans, Male, Middle Aged, Parathyroid Glands metabolism, Promoter Regions, Genetic genetics, RNA, Messenger metabolism, Adenoma genetics, DNA Methylation genetics, Histones genetics, Nuclear Proteins genetics, Parathyroid Neoplasms genetics, Transcription Factors genetics
- Abstract
Context: Glial cells missing 2 (GCM2), a zinc finger-transcription factor, is essentially required for the development of the parathyroid glands., Objective: We sought to identify whether the epigenetic alterations in GCM2 transcription are involved in the pathogenesis of sporadic parathyroid adenoma. In addition, we examined the association between promoter methylation and histone modifications with disease indices., Methods: Messenger RNA (mRNA) and protein expression of GCM2 were analyzed by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry in 33 adenomatous and 10 control parathyroid tissues. DNA methylation and histone methylation/acetylation of the GCM2 promoter were measured by bisulfite sequencing and chromatin immunoprecipitation-qPCR. Additionally, we investigated the role of epigenetic modifications on GCM2 and DNA methyltransferase 1 (DNMT1) expression in parathyroid (PTH)-C1 cells by treating with 5-aza-2'-deoxycytidine (DAC) and BRD4770 and assessed for GCM2 mRNA and DNMT1 protein levels., Results: mRNA and protein expression of GCM2 were lower in sporadic adenomatous than in control parathyroid tissues. This reduction correlated with hypermethylation (P < .001) and higher H3K9me3 levels in the GCM2 promoter (P < .04) in adenomas. In PTH-C1 cells, DAC treatment resulted in increased GCM2 transcription and decreased DNMT1 protein expression, while cells treated with the BRD4770 showed reduced H3K9me3 levels but a nonsignificant change in GCM2 transcription., Conclusion: These findings suggest the concurrent association of promoter hypermethylation and higher H3K9me3 with the repression of GCM2 expression in parathyroid adenomas. Treatment with DAC restored GCM2 expression in PTH-C1 cells. Our results showed a possible epigenetic landscape in the tumorigenesis of parathyroid adenoma and also that DAC may be a promising avenue of research for parathyroid adenoma therapeutics., (© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
39. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
- Author
-
Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, and Chen J
- Subjects
- Calcitriol administration & dosage, Female, Humans, Hyperparathyroidism, Secondary drug therapy, Hyperparathyroidism, Secondary metabolism, Hyperparathyroidism, Secondary pathology, Hyperplasia, Male, Middle Aged, NF-kappa B antagonists & inhibitors, Parathyroid Glands chemistry, Parathyroid Glands pathology, Parathyroid Hormone biosynthesis, Parathyroid Hormone genetics, Proliferating Cell Nuclear Antigen analysis, Pyrrolidines administration & dosage, Receptors, Calcitriol analysis, Receptors, Calcitriol drug effects, Receptors, Calcitriol metabolism, Thiocarbamates administration & dosage, Tissue Culture Techniques, Transcription Factor RelA analysis, Transcription, Genetic drug effects, Uremia complications, Uremia pathology, NF-kappa B physiology, Parathyroid Glands metabolism, Parathyroid Hormone metabolism, Uremia metabolism
- Abstract
Secondary hyperparathyroidism (SHPT) in uremic patients is characterized by parathyroid gland (PTG) hyperplasia and parathyroid hormone (PTH) elevation. Previously, we demonstrated that NF-κB activation contributed to parathyroid cell proliferation in rats with chronic kidney disease. Although vitamin D inhibits inflammation and ameliorates SHPT, the contribution of vitamin D deficiency to SHPT via local NF-κB activation remains to be clarified. PTGs collected from 10 uremic patients with advanced SHPT were used to test the expressions of vitamin D receptor (VDR), NF-κB, and proliferating cell nuclear antigen (PCNA). Freshly excised PTG tissues were incubated for 24 hours in vitro with VDR activator (VDRA) calcitriol or NF-κB inhibitor pyrrolidine thiocarbamate (PDTC). Chromatin immunoprecipitation (ChIP) and luciferase reporter assays were performed to investigate the regulation of PTH transcription by NF-κB. We found higher levels of activated NF-κB and lower expression of VDR in nodular hyperplastic PTGs than in diffuse hyperplasia. In cultured PTG tissues, treatment with VDRA or PDTC inhibited NF-κB activation and PCNA expression, and downregulated preproPTH mRNA and intact PTH levels. ChIP assays demonstrated the presence of NF-κB binding sites in PTH promoter. Furthermore, in luciferase reporter assays, addition of exogenous p65 significantly increased PTH luciferase activity by 2.4-fold (P < 0.01), while mutation of NF-κB binding site at position -908 of the PTH promoter suppressed p65-induced PTH reporter activity (P < 0.01). In summary, local NF-κB activation contributes to SHPT and mediates the transcriptional activation of PTH directly in uremic patients. Vitamin D deficiency may be involved in SHPT via the activation of NF-κB pathway., (© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
40. Heterogeneity of G protein activation by the calcium-sensing receptor.
- Author
-
Abid HA, Inoue A, and Gorvin CM
- Subjects
- Biomarkers, Cyclic AMP metabolism, Gene Expression Profiling, Gene Knockout Techniques, HEK293 Cells, Humans, Inositol 1,4,5-Trisphosphate metabolism, Kidney metabolism, Multigene Family, Organ Specificity genetics, Pancreas metabolism, Parathyroid Glands metabolism, Protein Binding, Protein Isoforms, Receptors, Calcium-Sensing genetics, GTP-Binding Proteins agonists, Receptors, Calcium-Sensing metabolism
- Abstract
The calcium-sensing receptor (CaSR) is a G protein-coupled receptor that plays a fundamental role in extracellular calcium (Ca2+e) homeostasis by regulating parathyroid hormone release and urinary calcium excretion. The CaSR has been described to activate all four G protein subfamilies (Gαq/11, Gαi/o, Gα12/13, Gαs), and mutations in the receptor that cause hyper/hypocalcaemia, have been described to bias receptor signalling. However, many of these studies are based on measurements of second messengers or gene transcription that occurs many steps downstream of receptor activation and can represent convergence points of several signalling pathways. Therefore, to assess CaSR-mediated G protein activation directly, we took advantage of a recently described NanoBiT G protein dissociation assay system. Our studies, performed in HEK293 cells stably expressing CaSR, demonstrate that Ca2+e stimulation activates all Gαq/11 family and several Gαi/o family proteins, although Gαz was not activated. CaSR stimulated dissociation of Gα12/13 and Gαs from Gβ-subunits, but this occurred at a slower rate than that of other Gα-subunits. Investigation of cDNA expression of G proteins in three tissues abundantly expressing CaSR, the parathyroids, kidneys and pancreas, showed Gα11, Gαz, Gαi1 and Gα13 genes were highly expressed in parathyroid tissue, indicating CaSR most likely activates Gα11 and Gαi1 in parathyroids. In kidney and pancreas, the majority of G proteins were similarly expressed, suggesting CaSR may activate multiple G proteins in these cells. Thus, these studies validate a single assay system that can be used to robustly assess CaSR variants and biased signalling and could be utilised in the development of new pharmacological compounds targeting CaSR.
- Published
- 2021
- Full Text
- View/download PDF
41. A Parathyroid-Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1.
- Author
-
Hackeng WM, Dreijerink KMA, Offerhaus GJA, and Brosens LAA
- Subjects
- Alleles, Duodenum pathology, Gastrinoma metabolism, Gastrinoma pathology, Germ-Line Mutation, Humans, Hypercalcemia metabolism, Models, Genetic, Multiple Endocrine Neoplasia Type 1 metabolism, Multiple Endocrine Neoplasia Type 1 pathology, Pancreatic Neoplasms metabolism, Pancreatic Neoplasms pathology, Parathyroid Glands pathology, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, Signal Transduction genetics, Duodenum metabolism, Gastrinoma genetics, Hypercalcemia genetics, Multiple Endocrine Neoplasia Type 1 genetics, Pancreatic Neoplasms genetics, Parathyroid Glands metabolism
- Abstract
Patients with multiple endocrine neoplasia 1 (MEN1) syndrome have a germline mutation in the MEN1 gene. Loss of the wild-type allele can initiate endocrine tumorigenesis. Microscopic and macroscopic pituitary, parathyroid, and pancreatic tumors (referred to as the 3 P's) show loss of the wild-type MEN1 allele up to 100%. In contrast, the duodenal gastrinoma pathogenesis in MEN1 syndrome follows a hyperplasia-to-neoplasia sequence. Gastrinomas have loss of heterozygosity of the MEN1 locus in <50%, and invariably coincide with linear, diffuse, or micronodular gastrin-cell hyperplasia. The factor initiating the gastrin-cell hyperplasia-to-neoplasia sequence is unknown. In this perspective, we argue that hypercalcemia may promote the gastrin-cell hyperplasia-to-neoplasia sequence through the calcium sensing receptor. Hypercalcemia is present in almost all patients with MEN1 syndrome due to parathyroid adenomas. We propose a parathyroid-gut axis, which could well explain why patients with MEN1 syndrome are regularly cured of duodenal gastrinoma after parathyroid surgery, and might cause MEN1 syndrome phenocopies in MEN1-mutation negative individuals with parathyroid adenomas. This perspective on the pathogenesis of the gastrin-cell hyperplasia and neoplasia sequence sheds new light on tumorigenic mechanisms in neuroendocrine tumors and might open up novel areas of gastrinoma research. It may also shift focus in the treatment of MEN1 syndrome-related gastrinoma to biochemical prevention., (©2021 American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
42. Etelcalcetide decreases the PTH-calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism.
- Author
-
Hayashi N, Imanishi Y, Hirakawa T, Kobayashi I, Tateishi T, Miyaoka D, Nagata Y, Mori K, Morioka T, Inoue A, Harada K, Inaba M, and Emoto M
- Subjects
- Animals, Calcium blood, Creatinine blood, Humans, Hyperparathyroidism, Primary blood, Magnesium blood, Male, Mice, Transgenic, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Hormone blood, Peptides administration & dosage, Peptides pharmacology, Phosphates blood, Receptors, Calcium-Sensing metabolism, Time Factors, Calcium metabolism, Hyperparathyroidism, Primary drug therapy, Parathyroid Hormone metabolism, Peptides therapeutic use
- Abstract
Introduction: Etelcalcetide binds to the extracellular domain of the calcium-sensing receptor (CaSR), while cinacalcet binds to the 7-transmembrane domain of the CaSR; however, it is unknown, whether etelcalcetide has similar effects to cinacalcet on parathyroid hormone (PTH) secretion., Materials and Methods: The PTH-calcium setpoint and maximum and minimum PTH secretion were determined using an 'in vivo setpoint analyses.' The PTH-calcium setpoint was obtained in a mouse model of primary hyperparathyroidism (PC) and wild-type (WT) mice, with PC mice divided into two groups. The setpoint was obtained after 7 days of etelcalcetide (3.0 mg/kg BW/day) or vehicle administration via anosmotic pump. After 7 days of crossover administration, the setpoint was obtained again. Parathyroid glands were obtained after crossover administration, and CaSR expression was analyzed by immunohistochemistry., Results: Etelcalcetide administration significantly decreased the setpoint from 9.03 ± 0.56 mg/dL to 6.80 ± 0.28 mg/dL, which was restored to 8.81 ± 0.38 mg/dL after vehicle administration. In the second group of mice, vehicle administration did not alter the setpoint (8.84 ± 0.69 mg/dL to 8.98 ± 0.63 mg/dL), but subsequent etelcalcetide administration significantly decreased it to 7.10 ± 0.72 mg/dL. There was no significant change in maximum and minimum PTH secretion. Expression levels of parathyroid CaSR were lower in PC mice than in WT mice; however, no significant differences were observed between the two mouse groups., Conclusion: Etelcalcetide decreased the PTH-calcium setpoint without changing maximum and minimum PTH secretion in PC mice, suggesting that like cinacalcet, etelcalcetide has calcimimetic potency.
- Published
- 2021
- Full Text
- View/download PDF
43. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
- Author
-
Xu M, Li H, Bai Y, He J, Chen R, An N, Li Y, and Dong Y
- Subjects
- Animals, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factor-23, HEK293 Cells, Humans, Hyperparathyroidism, Secondary etiology, Klotho Proteins, Mice, Mice, Inbred C57BL, Mice, Transgenic, Parathyroid Glands metabolism, Renal Insufficiency, Chronic complications, Reverse Transcriptase Polymerase Chain Reaction, Fibroblast Growth Factors metabolism, Glucuronidase metabolism, Hyperparathyroidism, Secondary prevention & control, MicroRNAs metabolism, Renal Insufficiency, Chronic metabolism, Signal Transduction
- Abstract
Background: Secondary hyperparathyroidism, a condition of excess parathyroid hormone (PTH, Pth) production, is often seen in chronic kidney disease (CKD) patients with elevated fibroblast growth factor 23 (FGF23, Fgf23). Elevated FGF23 levels stimulate secondary hyperparathyroidism-associated parathyroid αKlotho signaling. As overexpression of rationally selected microRNAs can suppress target gene activation, we hypothesized that microRNA-based suppression of parathyroid FGF23/αKlotho axis activity may be a potential strategy to combat secondary hyperparathyroidism., Methods: In vitro luciferase assays and human parathyroid adenoma cell experiments were used to determine miR-129-1-3p's effects on αKlotho expression in vitro. We also studied the effects of parathyroid-specific miR-129-1 overexpression (miR-129Ox) in CKD and non-CKD mice and parathyroid tissue cultures derived therefrom., Results: miR-129-1-3p directly targets the αKlotho mRNA strand in human parathyroid cells. miR-129Ox CKD mice and control CKD mice displayed comparable serum levels of calcium, phosphate, Fgf23, and 1,25-dihydroxyvitamin D (1,25(OH)
2 D). However, miR-129Ox CKD mice displayed reduced parathyroid αKlotho expression and lower circulating Pth levels. In vitro culture of miR-129Ox CKD murine parathyroid tissue showed suppressed responses to Fgf23, with decreased Pth secretion and diminished cell proliferation after four days., Conclusions: miR-129 negatively regulates pro-proliferative, Pth-inducing Fgf23/αKlotho signaling in the parathyroid glands of CKD mice., (Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
44. A Rapid Intraoperative Parathyroid Hormone Assay Based on the Immune Colloidal Gold Technique for Parathyroid Identification in Thyroid Surgery.
- Author
-
Xia W, Zhang J, Shen W, Zhu Z, Yang Z, and Li X
- Subjects
- Adult, Aged, Chromatography, Affinity methods, Female, Gold Colloid immunology, Humans, Hypoparathyroidism blood, Hypoparathyroidism diagnosis, Male, Middle Aged, Parathyroid Hormone immunology, Thyroid Gland surgery, Time Factors, Young Adult, Gold Colloid metabolism, Monitoring, Intraoperative methods, Parathyroid Glands metabolism, Parathyroid Hormone blood, Thyroid Gland metabolism, Thyroidectomy methods
- Abstract
Objective: A novel immunochromatographic test strip method was developed to detect tissue parathyroid hormone (PTH) using the immune colloidal gold technique (ICGT). The accuracy and application value of this method for intraoperative parathyroid identification were evaluated., Methods: Serum samples were collected to measure PTH by both ICGT and electrochemiluminescence immunoassay (ECLIA). Patients who underwent unilateral and total thyroidectomy were enrolled to evaluate the feasibility and clinical efficacy of rapid intraoperative identification of parathyroid glands via PTH determination using ICGT. Two sample preparation methods, fine needle aspiration (FNA) and tissue block homogenate (TBH), were used for PTH-ICGT analysis., Results: Bablok analysis showed a linear relationship between the serum PTH measurements obtained by ICGT and ECLIA. Non-parathyroid tissues had much lower PTH concentrations (14.8 ± 2.1 pg/ml, n = 97) detected by ICGT, compared to the parathyroid gland tissues (955.3 ± 16.1 pg/ml, n = 79; P < 0.0001), With biopsy results as the standard, ICGT showed higher diagnosis rates as compared with direct visual inspection, for identifying both parathyroid glands (97.4 vs. 78.2%) and non-parathyroid tissues (100 vs. 68.9%). The cut-off values for parathyroid identification by FNA and TBH methods were 63.99 and 136.30 pg/ml, respectively. The detection time was 2 min by TBH method for in vitro tissue detection and 6 min by FNA method for in situ tissue detection, both of which were faster than traditional intraoperative cryopathological examination (usually >30 min). Intraoperative application of ICGT method was associated with higher postoperative serum calcium and blood PTH levels at 1 and 3 months as well as a lower incidence of postoperative transient hypocalcemia, as compared with direct visual inspection., Conclusion: PTH-ICGT assay shows high potential as a rapid, novel alternative for intraoperative parathyroid identification., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Xia, Zhang, Shen, Zhu, Yang and Li.)
- Published
- 2021
- Full Text
- View/download PDF
45. Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid Tumors.
- Author
-
Tavanti GS, Verdelli C, Morotti A, Maroni P, Guarnieri V, Scillitani A, Silipigni R, Guerneri S, Maggiore R, Mari G, Vicentini L, Dalino Ciaramella P, Vaira V, and Corbetta S
- Subjects
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine analogs & derivatives, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine pharmacology, Adaptor Proteins, Signal Transducing metabolism, Amides pharmacology, Cell Nucleus drug effects, Cell Nucleus metabolism, Gene Expression drug effects, HEK293 Cells, Humans, Parathyroid Neoplasms metabolism, Phenethylamines pharmacology, Propylamines pharmacology, Protein Serine-Threonine Kinases genetics, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, Pyridines pharmacology, RNA Interference, Receptors, Calcium-Sensing agonists, Receptors, Calcium-Sensing metabolism, Transcription Factors metabolism, Tumor Cells, Cultured, Tumor Suppressor Proteins genetics, Tumor Suppressor Proteins metabolism, YAP-Signaling Proteins, rho-Associated Kinases antagonists & inhibitors, rho-Associated Kinases metabolism, Adaptor Proteins, Signal Transducing genetics, Parathyroid Glands metabolism, Parathyroid Neoplasms genetics, Receptors, Calcium-Sensing genetics, Transcription Factors genetics
- Abstract
The Hippo pathway is involved in human tumorigenesis and tissue repair. Here, we investigated the Hippo coactivator Yes-associated protein 1 (YAP1) and the kinase large tumor suppressor 1/2 (LATS1/2) in tumors of the parathyroid glands, which are almost invariably associated with primary hyperparathyroidism. Compared with normal parathyroid glands, parathyroid adenomas (PAds) and carcinomas show variably but reduced nuclear YAP1 expression. The kinase LATS1/2, which phosphorylates YAP1 thus promoting its degradation, was also variably reduced in PAds. Further, YAP1 silencing reduces the expression of the key parathyroid oncosuppressor multiple endocrine neoplasia type 1 (MEN1) , while MEN1 silencing increases YAP1 expression. Treatment of patient-derived PAds-primary cell cultures and Human embryonic kidney 293A (HEK293A) cells expressing the calcium-sensing receptor (CASR) with the CASR agonist R568 induces YAP1 nuclear accumulation. This effect was prevented by the incubation of the cells with RhoA/Rho-associated coiled-coil-containing protein kinase (ROCK) inhibitors Y27632 and H1152. Lastly, CASR activation increased the expression of the YAP1 gene targets CYR61 , CTGF , and WNT5A , and this effect was blunted by YAP1 silencing. Concluding, here we provide preliminary evidence of the involvement of the Hippo pathway in human tumor parathyroid cells and of the existence of a CASR-ROCK-YAP1 axis. We propose a tumor suppressor role for YAP1 and LATS1/2 in parathyroid tumors.
- Published
- 2021
- Full Text
- View/download PDF
46. What is the experience of our patients with transient hypoparathyroidism after total thyroidectomy?
- Author
-
Doubleday AR, Robbins SE, Macdonald CL, Elfenbein DM, Connor NP, and Sippel RS
- Subjects
- Adult, Aged, Calcium blood, Female, Follow-Up Studies, Humans, Hypocalcemia diagnosis, Hypocalcemia epidemiology, Hypocalcemia etiology, Hypoparathyroidism diagnosis, Hypoparathyroidism epidemiology, Hypoparathyroidism etiology, Male, Middle Aged, Parathyroid Glands injuries, Parathyroid Glands metabolism, Parathyroid Hormone blood, Parathyroid Hormone metabolism, Postoperative Complications diagnosis, Postoperative Complications epidemiology, Postoperative Complications etiology, Preoperative Period, Prospective Studies, Qualitative Research, Risk Factors, Thyroid Neoplasms blood, Young Adult, Hypocalcemia psychology, Hypoparathyroidism psychology, Postoperative Complications psychology, Quality of Life, Thyroid Neoplasms surgery, Thyroidectomy adverse effects
- Abstract
Background: We sought to better understand the experience of patients with transient hypoparathyroidism using patient interviews and quality of life surveys., Methods: This is a prospective analysis of 62 patients after total thyroidectomy at a high-volume institution. Semistructured patient interviews and quality of life surveys were conducted preoperatively and postoperatively at 2 weeks, 6 weeks, 6 months, and 1 year and compared based on postoperative parathyroid hormone levels., Results: Postoperative parathyroid hormone levels were <10 pg/mL in 32% of patients (n = 20), 10 to 20 pg/mL in 19% (n = 12), and >20 pg/mL in 48% (n = 30). Hypocalcemic symptoms at 2 weeks were reported in 28 of 55 patients (51%), but patients felt "well prepared" and reported it "wasn't a big deal." If symptoms persisted at 6 weeks, they became more bothersome. At 6 months and 1 year, patients reported calcium supplementation prevented most symptoms and did not interfere with daily activities. Quality of life as measured by the European Organization for Research and Treatment of Cancer and the 12-Item Short Form Survey demonstrated a slight improvement at 1 year postoperatively regardless of parathyroid hormone level., Conclusion: Early postoperative transient hypoparathyroidism is common but when appropriately managed did not have a substantial negative impact on the overall quality of life., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
47. Fine-needle aspiration of parathyroid adenomas: Indications as a diagnostic approach.
- Author
-
Suzuki A, Hirokawa M, Kanematsu R, Tanaka A, Yamao N, Higuchi M, Hayashi T, Kuma S, Miya A, and Miyauchi A
- Subjects
- Adenoma metabolism, Adult, Aged, Biopsy, Fine-Needle methods, Female, Humans, Male, Middle Aged, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Hormone metabolism, Parathyroid Neoplasms metabolism, Parathyroidectomy methods, Thyroid Neoplasms diagnosis, Thyroid Neoplasms metabolism, Thyroid Neoplasms pathology, Thyroid Nodule diagnosis, Thyroid Nodule metabolism, Thyroid Nodule pathology, Adenoma diagnosis, Adenoma pathology, Parathyroid Neoplasms diagnosis, Parathyroid Neoplasms pathology
- Abstract
Background: We aimed to determine the indication of fine-needle aspiration (FNA) for parathyroid adenoma (PA)-suspected nodules and the cytological features of PA, and to discuss the ancillary techniques for diagnostic confirmation., Method: Clinical, cytological, and histological examinations of 15 PA patients (4.0% of all PA resected patients) were conducted through FNA on 16 nodules. We also examined the cytological preparations of 10 follicular neoplasms (FNs) and 10 poorly differentiated thyroid carcinomas (PDTCs)., Results: FNA was performed to detect PA in nine (56.3%) nodules. The remaining seven (43.8%) nodules underwent FNA for lesions considered as thyroid nodules or lymph nodes. The levels of parathyroid hormone (PTH) in the aspiration needle washout fluid were observably high, except for that from one nodule with unsatisfactory FNA. Cytologically, the incidences of wedge pattern (86.7%) and salt and pepper chromatin (86.7%) in PAs were significantly higher than in FNs and PDTCs. In contrast, the appearance of colloid globules and nuclear grooves was less frequent than that of FNs and PDTCs. GATA-3 expression was intense in all PAs that immunocytochemistry were performed. Histologically, capsular invasion and/or laceration, tumor seeding, granulation tissue, and fibrosis were observed., Conclusions: When PA localization is unusual or inconclusive despite extensive imaging, FNA may be performed. We asserted that wedge pattern, salt and pepper chromatin, and the absence of colloid globules and nuclear grooves are diagnostic cytological indicators of PA rather than of FN or PDTC. We recommend PTH measurements using needle washout fluid for PA-suspected nodules, and immunocytochemistry with the GATA-3 antibody for cytologically PA-suspected nodules., (© 2020 The Authors. Diagnostic Cytopathology published by Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
48. The changing face of reoperative parathyroidectomy: a single-centre comparison of 147 parathyroid reoperations.
- Author
-
Camenzuli C, DiMarco AN, Isaacs KE, Grant Y, Jackson J, Alsafi A, Harvey C, Barwick TD, Tolley N, and Palazzo FF
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Fine-Needle statistics & numerical data, Female, Four-Dimensional Computed Tomography statistics & numerical data, Humans, Hyperparathyroidism, Primary blood, Hyperparathyroidism, Primary diagnosis, Hyperparathyroidism, Primary pathology, Male, Middle Aged, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Glands surgery, Parathyroid Hormone analysis, Parathyroid Hormone metabolism, Positron Emission Tomography Computed Tomography methods, Positron Emission Tomography Computed Tomography statistics & numerical data, Radionuclide Imaging, Recurrence, Retrospective Studies, Secondary Prevention statistics & numerical data, Technetium Tc 99m Sestamibi administration & dosage, Treatment Outcome, Ultrasonography statistics & numerical data, Young Adult, Hyperparathyroidism, Primary surgery, Parathyroid Glands diagnostic imaging, Parathyroidectomy statistics & numerical data, Reoperation statistics & numerical data, Secondary Prevention methods
- Abstract
Introduction: Reoperative parathyroidectomy for persistent and recurrent primary hyperparathyroidism is dependent on radiology. This study aimed to compare outcomes in reoperative parathyroidectomy at a single centre using a combination of traditional and newer imaging studies., Materials and Methods: Retrospective case note review of all reoperative parathyroidectomies for persistent and recurrent primary hyperparathyroidism over five years (June 2014 to June 2019; group A). Imaging modalities used and their positive predictive value, complications and cure rates were compared with a published dataset spanning the preceding nine years (group B)., Results: From over 2000 parathyroidectomies, 147 were reoperations (101 in group A and 46 in group B). Age and sex ratios were similar (56 vs 62 years; 77% vs 72% female). Ultrasound use remains high and shows better positive predictive value (76% vs 57 %). 99mTc-sestamibi use has declined (79% vs 91%) but the positive predictive value has improved (74% vs 53%). 4DCT use has almost doubled (61% vs 37%) with better positive predictive value (88% vs 75%). 18F-fluorocholine positron emission tomography-computed tomography and ultrasound-guided fine-needle aspiration for parathyroid hormone are novel modalities only available for group A. Both carried a positive predictive value of 100%. Venous sampling with or without angiography use has decreased (35% vs 39%) but maintains a high positive predictive value (86% vs 91%). Cure rates were similar (96% vs 100%). Group A had 5% permanent hypoparathyroidism, 1% permanent vocal cord palsy and 1% haematoma requiring reoperation. No complications for group B., Conclusion: Optimal imaging is key to good cure rates in reoperative parathyroidectomy. High-quality, non-interventional imaging techniques have produced a shift in the preoperative algorithm without compromising outcomes.
- Published
- 2021
- Full Text
- View/download PDF
49. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
- Author
-
Li T, Wang L, Wang H, Gao Y, Hu X, Li X, Zhang S, Xu Y, and Wei W
- Subjects
- Adult, Biomarkers blood, Bone and Bones metabolism, Bone and Bones pathology, Bone and Bones virology, C-Reactive Protein metabolism, COVID-19, Case-Control Studies, China epidemiology, Coronavirus Infections epidemiology, Coronavirus Infections pathology, Cross-Sectional Studies, Female, Ferritins blood, Fibrin Fibrinogen Degradation Products metabolism, Fibrinolysis, Hematopoiesis, Hemostasis, Humans, Liver metabolism, Liver pathology, Liver virology, Male, Middle Aged, Ovary metabolism, Ovary pathology, Ovary virology, Parathyroid Glands metabolism, Parathyroid Glands pathology, Parathyroid Glands virology, Pneumonia, Viral epidemiology, Pneumonia, Viral pathology, SARS-CoV-2, Serum Albumin metabolism, Severity of Illness Index, Testis metabolism, Testis pathology, Testis virology, Thyroid Gland metabolism, Thyroid Gland pathology, Thyroid Gland virology, Betacoronavirus pathogenicity, Coronavirus Infections blood, Coronavirus Infections diagnosis, Pandemics, Pneumonia, Viral blood, Pneumonia, Viral diagnosis
- Abstract
This study compared the laboratory indexes in 40 non-severe COVID-19 patients with those in 57 healthy controls. In the peripheral blood system of non-severe symptom COVID-19 patients, lymphocytes, eosinophils, basophils, total procollagen type 1 amino-terminal propeptide, osteocalcin N-terminal, thyroid-stimulating hormone, growth hormone, and insulin-like growth factor-binding protein 3 significantly decreased, and total protein, albumin, alanine transaminase, alkaline phosphatase, γ-glutamyl transferase, activated partial thromboplastin time, prothrombin time, fibrinogen, D-dimer, fibrinogen degradation products, human epididymal protein 4, serum ferritin, and C-reactive protein were elevated. SARS-CoV-2 infection can affect hematopoiesis, hemostasis, coagulation, fibrinolysis, bone metabolism, thyroid, parathyroid glands, the liver, and the reproductive system.
- Published
- 2020
- Full Text
- View/download PDF
50. Effect of fluoride on endocrine tissues and their secretory functions -- review.
- Author
-
Skórka-Majewicz M, Goschorska M, Żwierełło W, Baranowska-Bosiacka I, Styburski D, Kapczuk P, and Gutowska I
- Subjects
- Adrenal Glands metabolism, Animals, Fluorides adverse effects, Fluorides toxicity, Humans, Hydrocortisone metabolism, Insulin analysis, Parathyroid Glands drug effects, Parathyroid Glands metabolism, Sodium Fluoride pharmacology, Sodium Fluoride toxicity, Thyroid Gland drug effects, Thyroid Gland metabolism, Thyroid Hormones metabolism, Endocrine System drug effects, Fluorides pharmacology
- Abstract
The effects of fluoride on endocrine tissues has not been sufficiently explored to date. The current body of knowledge suggest significant effects of that mineral on reducing sex hormone levels, which may consequently impair fertility and disrupt puberty. The majority of studies confirm that sodium fluoride increases TSH levels and decreases the concentrations of T3 and T4 produced by the thyroid. Moreover, a correlation was observed between NaF and increased secretion of PTH by the parathyroid glands, without a significant impact on body calcium levels. Probably, fluoride may exert adverse effects on insulin levels, impairing pancreatic function and resulting in abnormal glucose tolerance. Observations also include decreased levels of cortisol secreted by the adrenal glands. In light of the few existing studies, the mechanism of fluoride toxicity on the endocrine system has been described., Competing Interests: Declaration of competing interest The authors declare that there are no conflicts of interest in the present work., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.